Other sleep disorders

G6_SLEEPDISOTH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G47 Hospital discharge: ICD-9 — 3478\|3074 Hospital discharge: excluded ICD-10 — G47.3, G47.4 Cause of death: ICD-10 — G47 Cause of death: ICD-9 — 3478\|3074 Cause of death: excluded ICD-10 — G47.3, G47.4 2 out of 7 registries used, show all original rules.	4794
4. Check minimum number of events None	4794
5. Include endpoints None	4794
6. Filter based on genotype QC (FinnGen only)	4794

Control definitions (FinnGen only)

Control exclude: G6_EPIPAROX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G40-G47
Name in latin: Perturbationes somni (organicae)

NAME	G6_SLEEPDISOTH
CONTROL_EXCLUDE	G6_EPIPAROX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G47
HD_ICD_9	3478\|3074
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	G47[3-4]
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G47
COD_ICD_9	3478\|3074
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	G47[3-4]
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other sleep disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37822	14792	22784
Only index persons	33930	13696	20234
Unadjusted period prevalence (%)
Whole population	0.55	0.42	0.64
Only index persons	0.66	0.50	0.77
Median age at first event (years)
Whole population	48.61	48.62	48.49
Only index persons	47.84	48.07	47.68

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4794	2287	2507
Unadjusted period prevalence (%)	0.95	0.78	1.11
Median age at first event (years)	49.42	47.28	51.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4246: Matched controls
42469

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

323.0

547

R5140

NOMESCO Finland

Monitoring the use of the aid

20.3

323.0

737

434

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

56.5

323.0

816

178

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

4053.9

323.0

381

G47.3

ICD-10 Finland

Sleep apnoea

95.4

323.0

2212

478

R06.5

ICD-10 Finland

Mouth breathing

11.2

323.0

795

855

G47.9

ICD-10 Finland

Sleep disorder, unspecified

310.7

323.0

2056

128

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

515.9

294.3

290

N06AX11

ATC

mirtazapine; oral

3.6

288.9

1826

7436

WX722

NOMESCO Finland

PEEP

18.8

270.2

427

251

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.4

258.0

668

1050

N05AH04

ATC

quetiapine; oral

4.2

241.3

1092

3255

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

233.5

222

XG466

NOMESCO Finland

Sleep oxymetry

21.2

232.0

351

180

G47.8

ICD-10 Finland

Other sleep disorders

43.3

226.1

283

WX780

NOMESCO Finland

Remote monitoring CPAP

2130.8

221.6

213

WX723

NOMESCO Finland

CPAP therapy

245.3

205.7

210

3478X

ICD-9 Finland

Cataplexy and narcolepsy[MUUT ORGANISET UNIHÄIRIÖT]

+∞

203.8

194

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

193.2

184

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

36.9

188.5

244

G44.2

ICD-10 Finland

Tension-type headache

5.6

181.7

581

1176

N06AX16

ATC

venlafaxine; oral

3.9

176.9

831

2483

N06AB04

ATC

citalopram; systemic

3.2

174.2

1139

4408

F51.0

ICD-10 Finland

Nonorganic insomnia

3.8

167.3

814

2496

R53

ICD-10 Finland

Malaise and fatigue

3.2

164.0

1043

3931

P06

ICPC

Sleep disturbance

4.9

160.9

583

1348

N05CF01

ATC

zopiclone; oral

2.6

157.9

1546

7632

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.9

157.5

733

2153

Z01.8

ICD-10 Finland

Other specified special examinations

3.0

156.4

1124

4588

N06AX21

ATC

duloxetine; oral

4.4

155.6

627

1611

N03AX16

ATC

pregabalin; oral

2.7

137.3

1130

4961

N05BA04

ATC

oxazepam; oral

2.6

134.5

1196

5485

R51.80

ICD-10 Finland

Headache

3.5

132.9

698

2243

E66.01

ICD-10 Finland

Obesity due to excess calories

5.1

131.8

448

957

R03AC02

ATC

salbutamol; inhalant

2.2

128.8

2255

14441

N03AE01

ATC

clonazepam; systemic

5.4

128.2

414

833

R06.0

ICD-10 Finland

Dyspnoea

2.6

128.1

1118

5048

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.0

126.5

559

1548

G40.9

ICD-10 Finland

Epilepsy, unspecified

219.8

124.4

128

N04BC05

ATC

pramipexole; oral

4.7

122.0

450

1046

N06AB10

ATC

escitalopram; oral

2.7

121.4

976

4179

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.3

120.7

483

1217

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

10.8

117.5

234

228

N03AG01

ATC

valproic acid; systemic, rectal

5.9

115.8

343

620

G43.9

ICD-10 Finland

Migraine, unspecified

10.4

114.9

233

235

N02AX02

ATC

tramadol; systemic, rectal

2.2

114.5

1820

10960

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

8.8

113.9

254

304

N06AB03

ATC

fluoxetine; oral

3.2

113.7

690

2447

N03AX12

ATC

gabapentin; oral

3.0

112.6

736

2747

A02BC02

ATC

pantoprazole; systemic

2.0

104.5

2632

18890

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.4

104.1

406

992

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.8

103.7

477

1356

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

3.6

103.1

516

1574

N06AX12

ATC

bupropion; oral

4.6

103.0

384

897

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

102.7

1136

5715

N03AX09

ATC

lamotrigine; oral

6.0

101.9

299

532

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

101.7

811

3412

E66.8

ICD-10 Finland

Other obesity

5.9

100.1

298

540

E66.00

ICD-10 Finland

Metabolic syndrome

5.3

99.4

323

650

N06AA09

ATC

amitriptyline; systemic

3.6

98.4

498

1530

M54.5

ICD-10 Finland

Low back pain

2.2

98.2

1400

7891

N06AX03

ATC

mianserin; oral

5.0

96.6

331

706

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

95.3

1492

8729

N05CF02

ATC

zolpidem; oral

2.6

95.3

836

3699

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

320.6

94.3

R01AD09

ATC

mometasone; nasal

2.0

94.2

1856

11902

N05BA01

ATC

diazepam; systemic, rectal

2.9

93.8

652

2506

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

93.4

535

1804

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.4

93.1

490

1550

N05CD07

ATC

temazepam; oral

3.0

92.8

601

2207

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

4.8

92.5

332

743

M79.6

ICD-10 Finland

Pain in limb

2.1

92.5

1448

8447

N06AB06

ATC

sertraline; oral

3.1

92.0

556

1947

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

90.2

1209

6581

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

8.3

89.7

207

261

N06AA12

ATC

doxepin; systemic

4.6

89.4

333

774

AA1AD

NOMESCO Finland

CT of head and brain

2.4

86.9

870

4108

H02AB06

ATC

prednisolone; systemic

1.9

86.6

1894

12505

XA420

NOMESCO Finland

Extensive sleep examination

37.6

85.8

110

R42

ICD-10 Finland

Dizziness and giddiness

2.4

85.6

855

4029

A02BC05

ATC

esomeprazole; systemic

2.0

85.3

1645

10342

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.9

85.0

297

645

N06AX26

ATC

vortioxetine; oral

4.4

84.3

324

776

A02BC03

ATC

lansoprazole; oral

2.1

82.0

1198

6718

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

81.7

985

5074

M03BX02

ATC

tizanidine; oral

1.9

81.2

2466

18121

N02BE01

ATC

paracetamol; systemic, rectal

2.1

81.1

3495

29206

C07AA05

ATC

propranolol; systemic

2.4

80.0

832

3988

C07AB07

ATC

bisoprolol; oral

1.9

80.0

1790

11800

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

79.2

391

1170

N03AF02

ATC

oxcarbazepine; oral

12.9

79.0

143

114

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

272.5

78.8

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

78.6

2144

15111

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.5

78.2

392

1186

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

77.9

1868

12579

A02BC01

ATC

omeprazole; systemic

2.1

77.8

1132

6311

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

76.9

1718

11272

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.2

76.0

440

1483

C03CA01

ATC

furosemide; systemic

2.1

75.5

1058

5793

J01AA02

ATC

doxycycline; systemic

1.9

74.0

3127

25305

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.2

73.4

937

4919

N06BA07

ATC

modafinil; oral

45.9

73.3

E66.9

ICD-10 Finland

Obesity, unspecified

6.6

72.9

196

310

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.8

71.3

514

1999

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.9

70.7

307

822

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.8

70.4

246

533

A02BA02

ATC

ranitidine; systemic

2.2

69.7

815

4100

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

689.2

69.2

N06AG02

ATC

moclobemide; oral

4.4

68.1

264

636

N05AA02

ATC

levomepromazine; systemic

4.3

67.9

270

666

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.2

67.8

814

4140

SPAT1263

SPAT

Sampling

1.8

67.1

1729

11735

N05AH03

ATC

olanzapine; systemic

3.5

66.6

337

1024

P76

ICPC

Depressive disorder

3.7

66.5

313

897

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

230.2

66.4

SPAT1240

SPAT

Therapeutic discussion

2.7

66.2

512

2073

N03AX11

ATC

topiramate; oral

10.6

65.9

131

127

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

+∞

65.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

65.7

1489

9670

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

7.9

65.6

155

203

J34.2

ICD-10 Finland

Deviated nasal septum

3.8

65.0

290

794

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

64.9

1116

6561

R01AD08

ATC

fluticasone; nasal

1.9

64.8

1155

6886

N05BA12

ATC

alprazolam; oral

2.7

64.2

482

1918

N06AX05

ATC

trazodone; oral

6.3

64.1

177

290

J01DB01

ATC

cefalexin; oral

1.9

63.2

3330

28046

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

61.8

1065

6250

P03

ICPC

Feeling depressed

2.8

61.6

422

1584

M79.7

ICD-10 Finland

Fibromyalgia

5.6

61.1

186

345

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

+∞

60.5

L03

ICPC

Low back symptom/complaint

2.0

60.3

940

5298

A10BA02

ATC

metformin; oral

1.9

60.2

1069

6332

M79.1

ICD-10 Finland

Myalgia

2.5

60.2

540

2368

N06AB05

ATC

paroxetine; oral

3.4

60.1

309

949

N06BA04

ATC

methylphenidate; oral

7.0

60.1

154

228

ENC30

NOMESCO Finland

Plastic operation of pharynx

11.1

59.9

116

107

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.0

59.5

252

658

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.9

59.1

383

1386

N06AA06

ATC

trimipramine; systemic

5.8

58.6

172

305

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

58.4

931

5284

R03BA05

ATC

fluticasone; inhalant

2.1

58.0

758

3970

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

58.0

644

3136

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.8

57.4

407

1559

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

57.4

F34.1

ICD-10 Finland

Dysthymia

4.8

57.4

200

432

M25.5

ICD-10 Finland

Pain in joint

1.9

57.0

1088

6587

G43.3

ICD-10 Finland

Complicated migraine

37.1

57.0

SPAT1262

SPAT

Handing over of treatment supplies

2.1

57.0

751

3946

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.9

56.9

384

1426

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

56.9

2804

22642

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.2

56.8

228

567

A04

ICPC

Weakness/tiredness general

2.4

56.2

533

2400

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.6

56.2

467

1960

N03AF01

ATC

carbamazepine; oral, rectal

4.1

55.4

228

580

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

17.3

55.1

R03DC03

ATC

montelukast; oral

2.2

55.0

639

3170

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.3

55.0

213

512

N05AX08

ATC

risperidone; systemic

2.9

54.8

362

1323

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

54.5

1029

6192

SPAT1377

SPAT

Polysomnography

6.5

54.5

146

230

4471

FHL

Pharyngoplasty

50.7

54.1

SBB10

NOMESCO Finland

Teeth copy

3.2

54.0

304

996

P29

ICPC

Psychological sympt/compl other

3.4

54.0

285

892

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

54.0

833

4651

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

53.8

1544

10618

T90

ICPC

Diabetes non-insulin dependent

1.9

53.8

877

5000

AA40B

NOMESCO Finland

141.8

52.9

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

52.5

567

2718

J01DA01

ATC

[U] cefalexin; systemic

1.6

52.4

2471

19468

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

52.0

943

5581

R01AD12

ATC

fluticasone furoate; nasal

1.8

51.8

1132

7136

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

51.8

1662

11772

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.1

51.5

169

342

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.0

51.0

323

1147

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

50.7

2156

16457

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

50.7

1132

7177

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.4

50.3

191

450

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

50.0

815

4634

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

49.8

1433

9808

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

49.2

1873

13837

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

48.9

1580

11156

SPAT1301

SPAT

No procedures

1.7

48.8

1221

8003

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

48.8

673

3580

H03AA01

ATC

levothyroxine sodium; systemic

1.9

48.8

831

4793

R06AE07

ATC

cetirizine; oral

1.7

48.7

1649

11791

UJF32

NOMESCO Finland

Coloscopy

1.8

48.7

964

5862

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.5

48.7

240

712

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.6

48.4

377

1520

J02AC01

ATC

fluconazole; systemic

1.7

48.2

1435

9893

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.4

48.1

445

1970

DJD20

NOMESCO Finland

Plastic repair of septum of nose

4.0

47.5

200

519

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

47.4

1538

10848

J01CA04

ATC

amoxicillin; systemic

1.7

47.4

3231

27709

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

47.4

380

1557

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.8

47.2

164

353

T82

ICPC

Obesity

4.7

47.2

168

371

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

47.0

1973

14888

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

46.8

654

3492

J31.0

ICD-10 Finland

Chronic rhinitis

2.8

46.6

332

1270

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

46.6

1422

9847

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.7

46.4

138

249

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

46.4

618

3234

K07.60

ICD-10 Finland

Snapping jaw

3.5

46.3

233

702

J01FA06

ATC

roxithromycin; oral

1.6

46.3

1519

10728

G45.3

ICD-10 Finland

Amaurosis fugax

47.2

46.1

N05AX12

ATC

aripiprazole; systemic

3.8

46.0

206

565

J45.1

ICD-10 Finland

Nonallergic asthma

2.8

45.7

308

1139

M01AB05

ATC

diclofenac; systemic, rectal

1.6

45.6

2562

20741

L17

ICPC

Foot/toe symptom/complaint

1.8

45.3

934

5733

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.9

45.3

295

1067

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

45.1

2501

20154

K02.1

ICD-10 Finland

Caries of dentine

1.6

44.7

2223

17419

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

19.2

44.4

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

12.7

44.4

R96

ICPC

Asthma

2.6

44.3

356

1460

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

44.2

1207

8073

P01AB01

ATC

metronidazole; oral, rectal

1.6

44.1

1467

10363

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

44.1

2069

15958

R40.0

ICD-10 Finland

Somnolence

27.6

43.8

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

4.5

43.8

162

372

A06AD11

ATC

lactulose; oral

2.1

43.7

529

2655

R52.9

ICD-10 Finland

Pain, unspecified

2.6

43.5

344

1398

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.3

43.5

227

704

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

43.4

610

3256

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

431.9

43.3

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

18.4

43.1

TAB00

NOMESCO Finland

Lumbar puncture

3.5

42.9

209

614

DHB50

NOMESCO Finland

Turbinoplasty

5.0

42.7

143

296

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

42.7

2211

17408

C08CA01

ATC

amlodipine; oral

1.7

42.5

1234

8379

M01AH02

ATC

rofecoxib; oral

2.2

42.5

492

2420

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.1

42.4

247

827

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

42.4

783

4624

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

42.0

1021

6579

SPAT1310

SPAT

Counselling related to known health issue

1.7

41.9

1219

8274

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

41.7

285

1062

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

41.6

777

4600

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

41.6

672

3778

SPAT1094

SPAT

Continuous Positive Airway Pressure

55.0

41.5

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.6

41.4

149

333

R55

ICD-10 Finland

Syncope and collapse

2.3

41.2

406

1851

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.8

41.0

125

L28

ICPC

Limited function/disability (L)

2.1

40.9

542

2821

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

40.8

866

5345

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

40.7

WX110

NOMESCO Finland

Local anesthesy

1.6

40.6

2683

22261

H53.1

ICD-10 Finland

Subjective visual disturbances

3.1

40.5

239

810

EB1MA

NOMESCO Finland

Cephalometry with X-ray

5.5

40.1

122

227

KMAK

NOMESCO Finland

1.5

40.0

1994

15459

R52.2

ICD-10 Finland

Other chronic pain

4.1

39.9

162

407

J01MA02

ATC

ciprofloxacin; systemic

1.6

39.8

1454

10450

R04

ICPC

Breathing problem other

4.1

39.7

159

395

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.9

39.5

262

957

N05BE01

ATC

buspirone; oral

4.0

39.5

164

421

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

38.9

313

1282

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

38.8

1056

7003

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.4

38.8

199

609

P01

ICPC

Feeling anxious/nervous/tense

2.2

38.7

414

1959

R03BA02

ATC

budesonide; inhalant

1.9

38.7

645

3661

R01AD01

ATC

beclometasone; nasal

2.0

38.6

585

3206

N06AX18

ATC

reboxetine; oral

8.1

38.6

110

R03BA01

ATC

beclometasone; inhalant

2.0

38.5

526

2768

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.6

38.5

179

507

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.7

38.4

135

295

F45.8

ICD-10 Finland

Other somatoform disorders

2.6

38.2

289

1143

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

38.2

378

1723

160

Kela drug reimbursment

exenatide

6.4

38.1

103

165

A28

ICPC

Limited function/disability NOS

2.0

37.8

505

2632

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

37.8

693

4066

R03BB04

ATC

tiotropium bromide; inhalant

2.3

37.7

378

1734

J01FF01

ATC

clindamycin; systemic

1.7

37.6

1015

6707

SPAT1312

SPAT

General health counselling

1.6

37.6

1223

8503

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

37.5

542

2915

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

37.1

504

2641

N05AF03

ATC

chlorprothixene; systemic

3.9

37.1

161

430

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.1

37.0

148

367

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

36.8

607

3429

N06AA04

ATC

clomipramine; systemic

5.6

36.7

110

201

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

36.7

1261

8880

3074F

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIVALVERYTMIN HÄIRIÖ]

+∞

36.5

ZXC60

NOMESCO Finland

Application of heat

6.2

36.4

100

164

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

36.3

324

1404

R02

ICPC

Shortness of breath/dyspnoea

2.1

36.3

433

2150

M01AH05

ATC

etoricoxib; oral

1.5

36.3

2154

17223

C07AB02

ATC

metoprolol; systemic

1.8

36.2

695

4132

N06AB08

ATC

fluvoxamine; oral

4.1

36.2

146

365

E66.0

ICD-10 Finland

Obesity due to excess calories

8.9

36.2

N06AX22

ATC

agomelatine; oral

5.0

36.1

120

247

F61.0

ICD-10 Finland

Mixed personality disorders

5.7

36.1

107

193

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.2

36.1

400

1922

K30

ICD-10 Finland

Functional dyspepsia

2.2

35.9

388

1845

J01FA10

ATC

azithromycin; systemic

1.5

35.7

2165

17366

205

Kela drug reimbursment

Chronic hypertension

1.7

35.7

935

6112

N05AB03

ATC

perphenazine; systemic, rectal

3.4

35.4

179

542

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

35.4

752

4617

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

35.3

262

1026

C01DA14

ATC

isosorbide mononitrate; oral

2.0

35.1

503

2692

G04BD12

ATC

mirabegron; oral

2.2

34.9

364

1702

XA800

NOMESCO Finland

Neuropsychological investigation

3.4

34.8

177

538

SPAT1254

SPAT

Administration of medicine

1.9

34.8

538

2962

SPAT1260

SPAT

Consultation of another employee

1.8

34.5

652

3851

S18

ICPC

Laceration/cut

1.5

34.5

1510

11233

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

34.4

G44.0

ICD-10 Finland

Cluster headache syndrome

23.6

34.4

SPAT1051

SPAT

Guidance regarding sleep disorders

6.7

34.4

135

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

34.3

491

2624

N03AX14

ATC

levetiracetam; systemic

10.3

34.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

34.2

1549

11606

M01AE02

ATC

naproxen; oral, rectal

1.5

34.2

2116

16979

D07AC01

ATC

betamethasone; topical

1.6

34.1

1251

8918

R60.0

ICD-10 Finland

Localized oedema

2.2

34.1

384

1856

R99

ICPC

Respiratory disease other

6.9

33.8

127

M02AA07

ATC

piroxicam; topical

1.6

33.7

1262

9035

WZA90

NOMESCO Finland

Other doctors statement

1.7

33.5

876

5712

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.3

33.3

104

200

C10AA05

ATC

atorvastatin; oral

1.6

33.3

1278

9203

A03FA02

ATC

cisapride; oral, rectal

2.4

33.2

287

1222

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

4.4

33.0

124

290

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

33.0

435

2249

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

33.0

323

1462

C09CA06

ATC

candesartan; oral

1.8

32.8

701

4301

M54.2

ICD-10 Finland

Cervicalgia

2.5

32.8

263

1074

N02CC03

ATC

zolmitriptan; nasal, oral

3.1

32.8

186

611

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

32.7

298

1303

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

32.5

375

1833

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

7.6

32.4

103

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

32.4

837

5430

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

32.4

579

3351

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

32.2

1463

10930

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

32.0

1587

12080

A10BJ02

ATC

liraglutide; parenteral

5.2

32.0

102

201

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.8

32.0

212

775

F32.1

ICD-10 Finland

Moderate depressive episode

2.8

31.9

220

824

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

31.9

348

1659

R03AC03

ATC

terbutaline; inhalant

1.9

31.9

509

2829

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

31.8

827

5371

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

31.7

201

715

R05

ICD-10 Finland

Cough

1.7

31.7

679

4166

R39.1

ICD-10 Finland

Other difficulties with micturition

3.4

31.6

159

480

J45.8

ICD-10 Finland

Mixed asthma

3.7

31.6

143

397

L01

ICPC

Neck symptom/complaint

2.0

31.5

465

2513

A10BH01

ATC

sitagliptin; oral

2.2

31.5

348

1670

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.2

31.4

141

S06.0

ICD-10 Finland

Concussion

2.1

31.4

387

1943

C10AA01

ATC

simvastatin; oral

1.5

31.4

1429

10663

R35

ICD-10 Finland

Polyuria

2.5

31.4

261

1089

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

31.4

520

2931

B01AC04

ATC

clopidogrel; oral

1.9

31.4

489

2697

E0000UV

ATC

1.5

31.2

1434

10724

H02AB07

ATC

prednisone; oral

1.9

31.1

509

2854

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

31.1

1455

10918

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

31.1

971

6622

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

31.1

361

1770

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

30.7

265

1126

Z00.0

ICD-10 Finland

General medical examination

1.7

30.7

675

4169

R03BA08

ATC

ciclesonide; inhalant

2.3

30.7

300

1356

G43.8

ICD-10 Finland

Other migraine

16.5

30.6

R05FB02

ATC

cough suppressants and expectorants

1.5

30.5

1305

9588

P74

ICPC

Anxiety disorder/anxiety state

3.2

30.5

169

549

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

30.4

458

2490

M48.0

ICD-10 Finland

Spinal stenosis

2.0

30.2

404

2098

K59.1

ICD-10 Finland

Functional diarrhoea

2.8

30.2

197

713

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

30.0

542

3143

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

29.8

1004

6962

Z71.8

ICD-10 Finland

Other specified counselling

1.6

29.8

853

5676

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

29.8

658

4069

R51

ICD-10 Finland

Headache

2.9

29.8

185

649

3007

Kela drug reimbursment

Erenumab and fremanezumab

28.8

29.8

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.9

29.7

125

326

L08

ICPC

Shoulder symptom/complaint

1.7

29.7

650

4005

-1

NOMESCO Finland

1.5

29.7

1247

9114

R11

ICD-10 Finland

Nausea and vomiting

2.3

29.7

291

1318

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

29.6

238

974

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.1

29.5

118

294

WX290

NOMESCO Finland

Other blockade of nerve

1.5

29.3

1643

12765

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

29.3

225

898

SPAT1097

SPAT

Recording of ECG

1.8

29.1

515

2965

A46

ICD-10 Finland

Erysipelas

1.9

29.0

492

2790

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

8.2

29.0

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.1

28.9

116

290

A10BX07

ATC

[U] liraglutide; parenteral

7.3

28.9

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.5

28.8

104

235

C08DA01

ATC

verapamil; systemic

3.2

28.7

155

494

G04CA02

ATC

tamsulosin; oral

1.6

28.7

869

5861

N02CC07

ATC

frovatriptan; oral

3.7

28.6

131

367

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.0

28.6

119

307

F32

ICD-10 Finland

Depressive episode

2.7

28.6

210

816

A02BC04

ATC

rabeprazole; oral

2.2

28.4

305

1441

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.8

28.4

122

324

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

28.3

446

2464

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

28.3

391

2056

NOMESCO Finland

Other rehabilitation services

+∞

28.1

SPAT1058

SPAT

PEF monitoring instruction

2.3

28.1

286

1319

SPAT1216

SPAT

Assessment of functional ability

1.8

28.1

505

2920

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

27.9

266

1188

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

27.8

595

3638

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

27.7

915

6298

UKC02

NOMESCO Finland

Cystoscopy

1.7

27.6

583

3550

A10AE04

ATC

insulin glargine; parenteral

2.0

27.5

359

1844

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

11.2

27.5

M01AX17

ATC

nimesulide; oral

1.6

27.5

829

5577

N02CC06

ATC

eletriptan; oral

3.9

27.5

116

304

P99

ICPC

Psychological disorders other

3.5

27.5

130

375

N05AN01

ATC

lithium; oral

3.7

27.5

122

334

G04BD08

ATC

solifenacin; oral

2.4

27.4

236

1002

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.4

27.4

139

423

M01AC06

ATC

meloxicam; systemic, rectal

1.5

27.3

1244

9217

R06AX27

ATC

desloratadine; oral

1.6

27.2

938

6523

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

8.7

27.2

214

Kela drug reimbursment

Severe and chronic narcolepsy

+∞

27.1

E66

ICD-10 Finland

Obesity

3.2

27.1

146

465

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

27.1

286

1340

XF402

NOMESCO Finland

ECG with work load test

2.0

27.1

386

2054

EBA00

NOMESCO Finland

Extraction of tooth

1.5

27.1

1215

8969

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.8

27.0

116

309

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

26.9

384

2042

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

26.8

204

810

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.6

26.8

211

R05

ICPC

Cough

1.6

26.8

767

5089

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.0

26.7

159

541

N01

ICPC

Headache

2.0

26.7

342

1744

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

26.4

482

2797

Z01.2

ICD-10 Finland

Dental examination

1.5

26.4

1478

11411

C05AA08

ATC

fluocortolone; rectal, topical

1.8

26.4

513

3041

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

26.4

331

1672

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.0

26.4

175

A01

ICPC

Pain general/multiple sites

2.2

26.3

269

1243

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

26.3

326

1640

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

3.0

26.2

158

544

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.1

26.2

310

1528

N02AA05

ATC

oxycodone; systemic

1.8

26.1

490

2871

H02AB04

ATC

methylprednisolone; systemic

1.8

26.1

505

2989

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.0

26.1

173

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

26.0

341

1753

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

26.0

970

6858

L15

ICPC

Knee symptom/complaint

1.6

26.0

681

4408

C10AA07

ATC

rosuvastatin; oral

1.6

25.9

790

5321

XKD00

NOMESCO Finland

Uroflowmetry

1.7

25.9

618

3892

162

Kela drug reimbursment

liraglutide

7.8

25.9

J46

ICD-10 Finland

Status asthmaticus

3.9

25.9

110

290

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.0

25.9

371

1978

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.3

25.9

228

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

25.8

465

2688

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.4

25.8

130

394

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

25.8

327

1661

N02CD01

ATC

erenumab; parenteral

28.5

25.3

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.1

25.3

100

247

SPAT1153

SPAT

Removal of sutures

1.5

25.3

1106

8096

G04BD04

ATC

oxybutynin; oral, transdermal

2.7

25.3

183

706

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.4

25.3

216

914

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

25.2

444

2545

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.2

25.2

273

1295

P20

ICPC

Memory disturbance

2.0

25.2

353

1863

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

25.1

985

7037

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

25.1

238

1062

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

25.1

484

2859

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

+∞

25.0

N30.0

ICD-10 Finland

Acute cystitis

1.8

25.0

433

2469

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

25.0

606

3835

J01FA09

ATC

clarithromycin; systemic

1.5

24.9

1094

8011

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.6

24.8

196

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.8

24.7

164

601

A08AB01

ATC

orlistat; oral

10.1

24.7

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

24.6

189

754

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

24.6

464

2719

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.9

24.5

104

274

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

24.5

653

4239

R25.1

ICD-10 Finland

Tremor, unspecified

3.4

24.4

123

373

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

24.4

214

918

ZXA10

NOMESCO Finland

Bilateral

1.6

24.4

643

4162

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

24.4

807

5538

J45

ICD-10 Finland

Asthma

2.0

24.3

320

1646

SPAT1229

SPAT

Assessment of need for aid

2.2

24.3

260

1229

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.1

24.2

140

469

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.7

24.2

535

3293

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

24.1

655

4271

J96.1

ICD-10 Finland

Chronic respiratory failure

4.2

24.0

221

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.8

24.0

159

581

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

24.0

1040

7583

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.9

24.0

167

C03DA01

ATC

spironolactone; oral

2.0

24.0

344

1833

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

23.9

148

518

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.9

23.8

115

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.8

23.8

153

550

R74

ICPC

Upper respiratory infection acute

1.5

23.7

974

7018

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

23.6

997

7224

A10BB12

ATC

glimepiride; oral

2.2

23.5

249

1167

J01MA12

ATC

levofloxacin; systemic

1.6

23.5

641

4185

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

23.4

722

4861

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

5.3

23.4

138

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

23.4

198

835

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

23.3

408

2331

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

23.2

235

1080

A10BJ06

ATC

semaglutide; parenteral

3.4

23.2

116

350

R07.3

ICD-10 Finland

Other chest pain

2.0

23.2

312

1621

F60.5

ICD-10 Finland

Anankastic personality disorder

6.8

23.0

XG460

NOMESCO Finland

Short time oxymetry

4.4

23.0

193

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

22.9

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

22.9

504

3095

SPAT1325

SPAT

Vaccination

1.4

22.8

1190

8995

C09CA01

ATC

losartan; oral

1.6

22.8

771

5308

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

22.7

478

2895

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

22.7

261

1272

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

22.7

1751

14228

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.9

22.6

156

S29

ICPC

Skin symptom/complaint other

1.7

22.6

563

3582

A10BK03

ATC

empagliflozin; oral

2.2

22.5

243

1152

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.0

22.5

136

470

R03AC12

ATC

salmeterol; inhalant

2.6

22.5

163

631

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

22.4

587

3784

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.6

22.4

103

292

C03AA03

ATC

hydrochlorothiazide; oral

2.0

22.4

301

1564

D07AD01

ATC

clobetasol; topical

1.7

22.3

519

3241

K59.0

ICD-10 Finland

Constipation

2.4

22.2

194

831

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.5

22.2

991

7250

G43

ICD-10 Finland

Migraine

3.1

22.2

127

422

C08CA13

ATC

lercanidipine; oral

1.8

22.2

398

2294

D11

ICPC

Diarrhoea

1.8

22.1

392

2249

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.1

22.1

126

418

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.5

22.0

182

756

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

21.9

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.6

21.9

101

287

R00.2

ICD-10 Finland

Palpitations

2.2

21.9

240

1145

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

62.8

21.8

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

21.8

348

1927

N02CC04

ATC

rizatriptan; oral

2.6

21.8

166

661

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

21.7

643

4283

AN1

Coronary angiography

1.8

21.6

388

2236

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

4.3

21.6

187

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.2

21.5

114

360

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.2

21.5

221

1025

G45.4

ICD-10 Finland

Transient global amnesia

15.3

21.5

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

21.5

2632

23035

G50.1

ICD-10 Finland

Atypical facial pain

4.7

21.4

161

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

21.4

239

1147

N06AA10

ATC

nortriptyline; systemic

4.0

21.3

223

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

21.2

161

637

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.0

21.2

214

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.3

21.2

193

845

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.8

21.2

138

501

R06.2

ICD-10 Finland

Wheezing

2.6

21.1

161

641

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

21.1

704

4819

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.2

21.1

225

1059

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

21.1

323

1762

N17

ICPC

Vertigo/dizziness

1.9

21.1

323

1762

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

21.0

1103

8322

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

21.0

227

1075

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.6

21.0

156

610

N02CD03

ATC

fremanezumab; systemic

60.3

20.9

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

60.3

20.9

N89

ICPC

Migraine

3.8

20.9

237

R21

ICPC

Throat symptom/complaint

1.6

20.8

670

4546

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

20.8

330

1819

L86

ICPC

Back syndrome with radiating pain

2.3

20.7

197

878

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.5

20.6

280

ZXA05

NOMESCO Finland

Left side

1.5

20.6

858

6176

F41.00

ICD-10 Finland

Moderate panic disorder

4.5

20.5

164

SPAT1234

SPAT

Support of social functional capacity

2.4

20.5

173

729

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

20.5

133

481

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.4

20.4

174

XQ800

NOMESCO Finland

Prick test

2.0

20.4

264

1351

B01AA03

ATC

warfarin; systemic

1.6

20.4

612

4079

XF404

NOMESCO Finland

Ambulatory ECG

1.9

20.4

310

1687

F51

ICD-10 Finland

Nonorganic sleep disorders

2.8

20.3

137

507

R49.01

ICD-10 Finland

Functional dysphonia

3.1

20.3

111

359

N05CD02

ATC

nitrazepam; oral

4.3

20.3

175

M03BX01

ATC

baclofen; systemic

4.1

20.3

194

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

4.4

20.2

171

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

20.2

270

1401

A11

ICPC

Chest pain NOS

2.1

20.1

239

1179

M01AX05

ATC

glucosamine; oral

1.6

20.1

584

3862

C09AA02

ATC

enalapril; systemic

1.6

20.1

639

4324

P25

ICPC

Phase of life problem adult

2.7

20.1

143

547

M01AB55

ATC

diclofenac, combinations; oral

2.1

20.0

224

1078

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.8

19.9

131

479

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

19.9

669

4586

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

19.8

282

Kela drug reimbursment

Sodium oxybat

+∞

19.8

M54.3

ICD-10 Finland

Sciatica

2.3

19.8

194

881

SFA00

NOMESCO Finland

Small filling

1.7

19.6

438

2698

G54.0

ICD-10 Finland

Brachial plexus disorders

3.5

19.6

276

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.4

19.6

164

687

E000001

ATC

1.5

19.6

717

5007

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

5.4

19.6

111

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.9

19.6

121

426

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

19.5

158

652

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

19.5

160

663

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

19.4

445

2764

WVA30

SPAT

2.9

19.3

119

418

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

19.3

845

6131

U02

ICPC

Urinary frequency/urgency

1.7

19.3

388

2314

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.8

19.3

339

1938

A01AB09

ATC

miconazole; local oral

1.9

19.3

291

1580

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

19.2

396

2380

M04AA01

ATC

allopurinol; systemic

1.7

19.2

421

2579

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

19.1

249

1275

G04CA01

ATC

alfuzosin; oral

1.7

19.0

427

2634

ZXA00

NOMESCO Finland

Right side

1.4

19.0

912

6740

SPAT1053

SPAT

Memory test

1.7

19.0

428

2640

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

19.0

294

1610

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

6.9

18.9

C08DB01

ATC

diltiazem; oral

2.3

18.9

177

786

G40.10

ICD-10 Finland

Simple partial seizures

+∞

18.8

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.7

18.7

219

R4110

SPAT

3.0

18.7

108

363

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

3.1

18.7

105

347

N05AF01

ATC

flupentixol; systemic

3.9

18.7

195

R03DA04

ATC

theophylline; systemic, rectal

2.3

18.6

173

766

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

8.6

18.6

G40

ICD-10 Finland

Epilepsy

100.5

18.6

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

18.5

672

4681

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

18.5

106

354

H02

ICPC

Hearing complaint

1.7

18.3

379

2279

M35.7

ICD-10 Finland

Hypermobility syndrome

4.9

18.2

125

XA421

NOMESCO Finland

Nocturnal polygraphy

25.1

18.2

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.4

18.2

256

N05AL01

ATC

sulpiride; systemic

4.1

18.2

171

R51.81

ICD-10 Finland

Facial pain NOS

3.8

18.2

210

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.4

18.1

148

A29

ICPC

General symptom/complaint other

1.7

18.1

367

2193

R50.9

ICD-10 Finland

Fever, unspecified

1.6

18.0

469

3011

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.5

18.0

141

571

R01AD11

ATC

triamcinolone; nasal

1.9

18.0

293

1631

SPAT1243

SPAT

Psychiatric/psychological examination

2.8

17.9

114

409

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

17.8

354

2106

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

17.7

G93.3

ICD-10 Finland

Postviral fatigue syndrome

10.4

17.6

R29

ICPC

Respiratory symptom/complaint other

2.1

17.6

203

992

J01DA06

ATC

[U] cefuroxime; systemic

1.6

17.6

486

3168

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

17.6

312

1789

Z00.8

ICD-10 Finland

Other general examinations

1.9

17.6

246

1299

N03AX18

ATC

lacosamide; systemic

95.4

17.6

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

17.5

204

998

T83

ICPC

Overweight

3.8

17.5

202

N06AA22

ATC

8.0

17.5

N07BB01

ATC

disulfiram; oral

2.2

17.4

172

785

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.1

17.4

169

A02BX02

ATC

sucralfate; oral

2.5

17.2

138

567

N05AD01

ATC

haloperidol; systemic

2.6

17.2

124

480

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

6.8

17.2

R13

ICD-10 Finland

Dysphagia

2.1

17.2

202

994

J01EA01

ATC

trimethoprim; systemic

1.5

17.2

751

5435

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

8.5

17.1

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.2

17.1

176

818

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.3

17.1

165

743

G04BD07

ATC

tolterodine; oral

2.3

17.1

162

723

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.3

17.1

258

L29

ICPC

Musculoskeletal sympt/complt other

2.0

17.1

232

1211

N06AX17

ATC

milnacipran; oral

5.0

17.1

108

M02AA10

ATC

ketoprofen; topical

1.6

17.1

497

3280

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

5.1

17.1

104

XG410

NOMESCO Finland

Flow-volume spirometry

2.4

17.1

149

641

UDC00

NOMESCO Finland

Ear microscopy

1.9

17.0

251

1349

L02

ICPC

Back symptom/complaint

1.8

17.0

281

1572

J20

ICD-10 Finland

Acute bronchitis

1.8

17.0

296

1688

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.8

17.0

108

387

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

16.9

124

483

M54.8

ICD-10 Finland

Other dorsalgia

2.5

16.9

132

536

AA400

NOMESCO Finland

Electroconvulsive therapy

5.7

16.9

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

16.7

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

16.7

D07AC13

ATC

mometasone; topical

1.4

16.6

964

7360

4211

FHL

Transeptal septal resection and reconstruction

5.0

16.5

108

G41.9

ICD-10 Finland

Status epilepticus, unspecified

170.6

16.5

C02AC05

ATC

moxonidine; oral

2.4

16.5

144

619

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.1

16.4

288

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

16.4

426

2732

F33

ICD-10 Finland

Recurrent depressive disorder

3.6

16.3

204

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

16.3

1096

8577

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

16.2

182

880

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

16.2

338

2037

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

16.2

186

908

D01

ICPC

Abdominal pain/cramps general

1.7

16.2

334

2007

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

16.2

199

999

SJB60

NOMESCO Finland

External device grinding and adaptation

4.4

16.2

133

G47

ICD-10 Finland

Sleep disorders

21.0

15.9

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.9

15.9

104

D01AC02

ATC

miconazole; topical

1.8

15.9

270

1524

R52.1

ICD-10 Finland

Chronic intractable pain

5.8

15.8

H93.1

ICD-10 Finland

Tinnitus

2.0

15.8

215

1122

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.4

15.8

231

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.3

15.7

137

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

15.7

316

1884

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

15.7

851

6408

M54

ICD-10 Finland

Dorsalgia

1.7

15.6

349

2145

R06AE09

ATC

levocetirizine; oral

1.6

15.6

471

3134

34609

ICD-8 Finland

Migraine, Unspecified

+∞

15.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

15.6

240

1311

Z01.7

ICD-10 Finland

Laboratory examination

1.7

15.6

360

2233

J01CA08

ATC

pivmecillinam; oral

1.4

15.6

1129

8931

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

15.6

501

3388

A02BA04

ATC

nizatidine; systemic

1.9

15.5

241

1320

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

15.5

656

4705

R12

ICD-10 Finland

Heartburn

1.9

15.5

225

1201

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

15.5

513

3493

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

15.4

193

975

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.5

15.3

210

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

4.5

15.3

122

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

15.3

265

1505

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.7

15.2

107

409

R5599

NOMESCO Finland

Other rehabilitation service

2.7

15.2

103

386

D07XC01

ATC

betamethasone, combinations; topical

1.6

15.2

404

2604

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

15.1

142

634

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

15.1

154

713

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

6.0

15.1

F33.8

ICD-10 Finland

Other recurrent depressive disorders

5.6

15.1

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

45.1

15.0

R03BB01

ATC

ipratropium bromide; inhalant

2.4

15.0

124

519

F32.8

ICD-10 Finland

Other depressive episodes

3.8

15.0

163

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

15.0

181

902

N02CC05

ATC

almotriptan; oral

2.7

15.0

105

401

J01AA07

ATC

tetracycline; systemic

1.5

14.9

511

3500

M03AX01

ATC

botulinum toxin; parenteral

6.1

14.9

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.0

14.9

187

945

N62

ICD-10 Finland

Hypertrophy of breast

2.3

14.8

133

578

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.9

14.8

304

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

14.8

125

529

F51.1

ICD-10 Finland

Nonorganic hypersomnia

31.8

14.8

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.7

14.8

180

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

5.2

14.8

H02AB09

ATC

hydrocortisone; systemic

2.9

14.8

305

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

14.8

213

1136

SJB10

NOMESCO Finland

Fitting of loose orthodontic device with user information, demanding

6.7

14.7

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

7.2

14.7

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

14.7

244

1370

R03AC13

ATC

formoterol; inhalant

2.1

14.7

165

797

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

14.7

379

2424

J01MA14

ATC

moxifloxacin; systemic

1.7

14.6

289

1713

D02AE01

ATC

carbamide; topical

1.9

14.6

222

1209

XG405

NOMESCO Finland

Education on PEF monitoring

3.6

14.6

182

N07XX04

ATC

sodium oxybate; oral

+∞

14.6

3074G

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNISSAKÄVELYHÄIRIÖ JA YÖLLINEN KAUHUKOHTAUS]

+∞

14.6

N05BA09

ATC

clobazam; oral

80.4

14.6

R41.0

ICD-10 Finland

Disorientation, unspecified

2.8

14.5

342

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

14.5

205

1087

C01CA24

ATC

epinephrine; parenteral

1.9

14.5

205

1087

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.8

14.5

258

1483

R41.3

ICD-10 Finland

Other amnesia

2.9

14.5

292

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.8

14.4

344

N88

ICPC

Epilepsy

36.1

14.4

K04.0

ICD-10 Finland

Pulpitis

1.7

14.3

310

1888

K03.00

ICD-10 Finland

Approximal wear

2.0

14.3

176

883

D09

ICPC

Nausea

2.3

14.3

138

624

SPAT1050

SPAT

Extensive neurological examination

3.3

14.3

217

S97

ICPC

Chronic ulcer skin

2.1

14.3

169

834

L14

ICPC

Leg/thigh symptom/complaint

1.9

14.3

225

1242

B01AC07

ATC

dipyridamole; systemic

2.5

14.2

111

450

L60.0

ICD-10 Finland

Ingrowing nail

2.2

14.2

141

647

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

14.2

127

554

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.8

14.2

342

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.8

14.2

252

1448

M01AH03

ATC

valdecoxib; oral

1.9

14.1

210

1133

SPAT1211

SPAT

Application of soft bandage

1.7

14.1

278

1649

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

14.1

618

4460

N04BD01

ATC

selegiline; oral

3.7

14.1

167

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

14.1

276

1634

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.7

14.0

354

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

14.0

641

4664

R07.0

ICD-10 Finland

Pain in throat

1.9

14.0

205

1099

A10AE05

ATC

insulin detemir; parenteral

2.0

14.0

185

958

Z08

ICPC

Social welfare problem

4.1

14.0

134

K08.80

ICD-10 Finland

Toothache NOS

1.8

14.0

246

1406

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

13.9

1227

9972

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

5.1

13.9

R03CA02

ATC

ephedrine; oral

15.8

13.9

WZC30

NOMESCO Finland

Teaching

1.5

13.9

437

2937

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

13.9

413

2738

R01AD05

ATC

budesonide; nasal

1.8

13.9

258

1504

F41.3

ICD-10 Finland

Other mixed anxiety disorders

4.0

13.8

140

S22.3

ICD-10 Finland

Fracture of rib

1.9

13.8

209

1135

A07AA02

ATC

nystatin; oral

1.9

13.8

189

991

H13

ICPC

Plugged feeling ear

1.5

13.8

562

3998

N06BA12

ATC

lisdexamfetamine; oral

9.7

13.7

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

13.7

114

480

A10BX04

ATC

[U] exenatide; parenteral

5.0

13.6

R30.0

ICD-10 Finland

Dysuria

2.4

13.6

117

501

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

13.6

155

756

R06.4

ICD-10 Finland

Hyperventilation

3.6

13.5

173

H57.1

ICD-10 Finland

Ocular pain

2.6

13.5

100

394

-50

ICPC

Medication/prescr/renewal

2.2

13.5

141

662

SPAT1043

SPAT

Audiometry

1.7

13.5

304

1874

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

13.5

415

2769

B01AB05

ATC

enoxaparin; parenteral

1.4

13.5

941

7372

K07.4

ICD-10 Finland

Malocclusion, unspecified

3.5

13.5

174

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

140.4

13.4

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.0

13.4

170

865

K07.13

ICD-10 Finland

Retrognaty, mandibular

3.7

13.4

154

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.4

13.4

190

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

13.4

518

3639

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

13.4

325

G04BD09

ATC

trospium; oral

2.9

13.4

288

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

13.4

478

3304

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

13.3

798

6094

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

13.3

331

2095

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

13.3

109

455

D19

ICPC

Teeth/gum symptom/complaint

1.4

13.3

865

6698

XKC03

NOMESCO Finland

Water cystometry

2.6

13.3

385

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.5

13.3

427

2885

EMB10

NOMESCO Finland

Tonsillectomy

1.9

13.2

191

1021

L13

ICPC

Hip symptom/complaint

1.5

13.2

438

2977

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.9

13.2

R5110

SPAT

2.7

13.2

338

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.3

13.2

126

569

H01

ICPC

Ear pain/earache

1.6

13.2

317

1991

A06AC51

ATC

ispaghula, combinations; systemic

2.1

13.1

154

759

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.9

13.1

265

A01AB04

ATC

amphotericin B; local oral

2.1

13.1

147

711

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

13.1

292

1796

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

13.1

104

427

R30.1

ICD-10 Finland

Vesical tenesmus

3.3

13.1

205

B02AA02

ATC

tranexamic acid; systemic

1.5

13.1

426

2885

SPAT1139

SPAT

Nutrition survey

2.4

13.0

107

447

K07

ICPC

Swollen ankles/oedema

2.3

13.0

121

537

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.1

13.0

233

X58

ICD-10 Finland

Exposure to other specified factors

1.5

13.0

450

3087

SPAT1059

SPAT

Spirometry at the office

2.0

13.0

158

793

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.0

13.0

255

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

6.0

13.0

N05AC02

ATC

thioridazine; oral

2.7

13.0

344

K89

ICPC

Transient cerebral ischaemia

8.8

13.0

K04.08

ICD-10 Finland

Other specified pulpit

1.8

12.9

215

1206

K04

ICPC

Palpitations/awareness of heart

2.0

12.9

161

813

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

12.9

226

1292

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

12.9

215

1210

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

12.9

157

788

4479

FHL

Other measure in this category

22.6

12.9

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

12.9

242

1415

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

12.8

260

1556

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

12.7

3475

32682

G44.8

ICD-10 Finland

Other specified headache syndromes

7.5

12.6

C08CA05

ATC

nifedipine; systemic

1.9

12.6

188

1019

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

12.6

325

2080

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

12.5

124

570

N39.3

ICD-10 Finland

Stress incontinence

1.9

12.5

189

1028

N30

ICD-10 Finland

Cystitis

1.8

12.5

208

1169

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

+∞

12.5

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

+∞

12.5

A05

ICPC

Feeling ill

1.9

12.5

189

1030

SPAT1104

SPAT

Monitoring of emergency patient

1.8

12.5

200

1109

Z29

ICPC

Social problem NOS

3.0

12.5

245

S20.2

ICD-10 Finland

Contusion of thorax

2.0

12.5

156

792

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

12.4

322

2062

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.4

12.4

170

L12

ICPC

Hand/finger symptom/complaint

1.5

12.4

436

3002

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.0

12.4

230

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.7

12.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

12.4

151

759

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

12.4

216

1235

C10AA03

ATC

pravastatin; oral

1.8

12.4

203

1137

Z73.0

ICD-10 Finland

Burn-out

2.5

12.3

398

SPAT1255

SPAT

Intravenous administration of medicine

1.8

12.3

212

1207

D82

ICPC

Teeth/gum disease

1.3

12.3

1152

9411

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

14.3

12.2

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.9

12.2

187

1022

R06AX22

ATC

ebastine; oral

1.4

12.2

525

3765

SPAT1283

SPAT

Restricted health certificate

1.4

12.2

564

4105

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.3

12.2

103

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

12.2

318

ACC51

NOMESCO Finland

Release of median nerve

1.8

12.2

216

1240

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.5

12.1

379

2540

W19

ICD-10 Finland

Unspecified fall

1.6

12.1

285

1778

U04

ICPC

Incontinence urine

2.2

12.1

123

572

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

12.1

666

5005

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

12.1

275

1700

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

12.1

195

1086

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

6.1

12.1

RK320

NOMESCO Finland

5.6

12.0

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.9

12.0

C09AA05

ATC

ramipril; oral

1.4

12.0

735

5627

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

12.0

167

885

J01FA01

ATC

erythromycin; systemic

1.5

11.9

450

3145

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

11.9

393

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.0

11.9

143

714

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.3

11.9

101

F31

ICD-10 Finland

Bipolar affective disorder

3.6

11.9

145

SPAT1251

SPAT

Organisation of medication

2.2

11.9

114

517

JAH01

NOMESCO Finland

Laparoscopy

2.0

11.9

145

730

L29.9

ICD-10 Finland

Pruritus, unspecified

2.9

11.9

249

N02AC04

ATC

dextropropoxyphene; oral

2.3

11.9

113

508

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.4

11.8

D12

ICPC

Constipation

2.3

11.8

106

466

F41.01

ICD-10 Finland

Severe panic disorder

6.4

11.8

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

6.1

11.8

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

11.7

104

451

C08CA02

ATC

felodipine; oral

1.7

11.7

265

1636

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

11.7

186

1030

M10.9

ICD-10 Finland

Gout, unspecified

1.8

11.7

199

1127

M43.1

ICD-10 Finland

Spondylolisthesis

2.2

11.7

118

549

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.9

11.7

234

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.4

11.7

R33

ICD-10 Finland

Retention of urine

1.7

11.6

249

1513

WZA10

NOMESCO Finland

Long statement of health and health related matters

3.2

11.6

185

N03AX15

ATC

zonisamide; oral

65.1

11.6

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

4.7

11.6

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.8

11.6

128

Z56.7

ICD-10 Finland

Other and unspecified problems related to employment

6.9

11.6

T07

ICPC

Weight gain

4.5

11.6

E000006

ATC

1.8

11.6

211

1223

L09

ICPC

Arm symptom/complaint

2.1

11.6

126

602

D01BA02

ATC

terbinafine; oral; topical

1.3

11.6

832

6528

I20.09

ICD-10 Finland

Unstable angina

1.9

11.6

159

835

RF211

NOMESCO Finland

22.9

11.6

H02.3

ICD-10 Finland

Blepharochalasis

1.8

11.5

181

1000

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

11.5

111

505

3074H

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[PARASOMNIA NUD]

+∞

11.5

N05AB04

ATC

prochlorperazine; systemic, rectal

3.0

11.4

215

AA43B

NOMESCO Finland

120.3

11.4

L16

ICPC

Ankle symptom/complaint

1.6

11.4

294

1880

I50.0

ICD-10 Finland

Congestive heart failure

1.8

11.4

184

1026

R19.5

ICD-10 Finland

Other faecal abnormalities

3.7

11.4

135

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.8

11.4

125

A10BK01

ATC

dapagliflozin; oral

2.0

11.4

141

712

C09DA06

ATC

candesartan and diuretics; oral

1.8

11.4

198

1129

D02

ICPC

Abdominal pain epigastric

1.9

11.4

168

908

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

11.4

152

793

J05AB01

ATC

aciclovir; systemic

1.4

11.4

635

4779

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.7

11.4

292

R4120

NOMESCO Finland

Occupational therapy

1.8

11.3

194

1100

A12BA01

ATC

potassium chloride; oral

2.1

11.3

122

580

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

7.9

11.3

H81

ICPC

Excessive ear wax

1.4

11.3

490

3520

N05AE04

ATC

ziprasidone; systemic

5.4

11.3

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

11.3

203

1172

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.4

11.3

157

SPAT1281

SPAT

Other administrative function

1.7

11.3

241

1466

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

11.3

149

774

N05CD08

ATC

midazolam; nasal, systemic

2.8

11.2

264

A10BB01

ATC

glibenclamide; oral

2.1

11.2

122

586

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

11.2

377

2571

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

11.2

135

675

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.4

11.2

368

WX002

NOMESCO Finland

Sedation and analgesia

1.4

11.2

595

4439

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

11.2

337

2241

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

11.2

168

913

U71

ICPC

Cystitis/urinary infection other

1.9

11.2

160

854

K07.23

ICD-10 Finland

Deep bite

2.7

11.1

276

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.5

11.1

343

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

11.1

702

5392

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

11.1

428

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

11.1

333

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

11.1

342

2284

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

11.1

225

1348

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

11.0

644

4883

F40.1

ICD-10 Finland

Social phobias

2.6

11.0

321

H29

ICPC

Ear symptom/complaint other

1.6

11.0

300

1946

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

11.0

233

1416

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

11.0

100

444

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.3

10.9

207

Kela drug reimbursment

Chronic arrhythmias

1.5

10.9

402

2793

WX723

SPAT

43.4

10.9

N05AB01

ATC

dixyrazine; systemic

3.2

10.9

178

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

10.9

218

1301

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

10.8

400

2783

IER01

NOMESCO Finland

Psychoeducation, group

5.7

10.8

N07CA01

ATC

betahistine; oral

1.7

10.8

211

1248

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.7

10.8

276

H81.3

ICD-10 Finland

Other peripheral vertigo

2.5

10.8

326

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.6

10.8

304

1988

R15

ICD-10 Finland

Faecal incontinence

2.6

10.8

294

F48.0

ICD-10 Finland

Neurasthenia

8.8

10.7

R4190

NOMESCO Finland

Nutritional therapy

2.2

10.7

109

509

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

10.7

376

XF405

NOMESCO Finland

Symptom ECG

5.4

10.7

N05CD05

ATC

triazolam; oral, sublingual

3.5

10.7

143

M01AC01

ATC

piroxicam; systemic, rectal

1.5

10.7

395

2750

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

10.7

349

2364

N04AA02

ATC

biperiden; systemic

2.5

10.7

322

C09DA01

ATC

losartan and diuretics; oral

1.6

10.6

292

1898

D07AB08

ATC

desonide; topical

1.5

10.6

322

2141

N02CC02

ATC

naratriptan; oral

3.6

10.6

133

QDH05

NOMESCO Finland

Correction of deformity of toe nail

6.7

10.6

SPAT1284

SPAT

Extensive health certificate

2.3

10.6

100

450

P28

ICPC

Limited function/disability (P)

4.5

10.6

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.2

10.6

110

517

F43.8

ICD-10 Finland

Other reactions to severe stress

2.8

10.6

236

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.1

10.6

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

10.6

237

R06AX13

ATC

loratadine; oral

1.4

10.6

473

3418

I20.00

ICD-10 Finland

Unstable angina

2.3

10.5

413

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.4

10.5

366

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

10.5

181

1031

C09BA02

ATC

enalapril and diuretics; systemic

1.6

10.5

246

1535

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

10.5

395

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.8

10.5

192

1117

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

10.5

134

688

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

10.4

403

2831

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

10.4

294

1924

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

10.4

515

3790

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

10.4

134

691

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.7

10.4

257

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

10.4

391

2731

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.7

10.4

248

WX704

NOMESCO Finland

Intubation

1.7

10.3

222

1354

RD210

NOMESCO Finland

2.9

10.3

219

U07

ICPC

Urine symptom/complaint other

1.8

10.3

165

917

L05

ICPC

Flank/axilla symptom/complaint

1.9

10.3

157

856

M01AB01

ATC

indometacin; systemic, rectal

1.7

10.3

228

1398

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

10.3

702

5454

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.2

10.3

106

499

A10BX01

ATC

guar gum; systemic

2.1

10.2

110

526

SPAT1252

SPAT

Overall medication plan or its review

1.7

10.2

195

1146

H02.4

ICD-10 Finland

Ptosis of eyelid

2.4

10.2

336

C10AX09

ATC

ezetimibe; oral

1.6

10.2

301

1991

R03BC03

ATC

nedocromil; inhalant

1.7

10.2

212

1278

K02

ICPC

Pressure/tightness of heart

2.6

10.2

278

R04.2

ICD-10 Finland

Haemoptysis

2.2

10.2

105

494

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

10.2

324

2183

SXC05

NOMESCO Finland

Other oral or dental procedure

1.8

10.2

178

1018

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

10.2

380

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.4

10.1

144

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.8

10.1

161

895

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

5.4

10.1

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

10.1

521

3865

SPAT1238

SPAT

Brief therapy

2.9

10.1

211

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.3

10.1

150

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

10.1

183

1061

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

10.1

317

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

4.8

10.0

K11.2

ICD-10 Finland

Sialoadenitis

2.2

10.0

457

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

10.0

155

853

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

10.0

104

491

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

10.0

301

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

10.0

111

539

F05.9

ICD-10 Finland

Delirium, unspecified

2.9

10.0

206

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.3

10.0

417

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

3.3

10.0

151

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.3

10.0

R4110

NOMESCO Finland

Physiotherapy

1.3

10.0

838

6714

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

5.1

10.0

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.9

10.0

100

D06

ICPC

Abdominal pain localized other

1.7

10.0

226

1396

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

9.9

247

1565

N41.1

ICD-10 Finland

Chronic prostatitis

2.4

9.9

340

G01AF04

ATC

miconazole; vaginal

2.0

9.9

132

687

C10AA04

ATC

fluvastatin; oral

1.6

9.9

236

1480

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.1

9.9

103

486

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.2

9.9

152

S21

ICPC

Skin texture symptom/complaint

1.5

9.9

363

2521

S80.0

ICD-10 Finland

Contusion of knee

1.7

9.9

185

1085

D07AA02

ATC

hydrocortisone; topical

1.4

9.9

434

3124

P58

ICPC

Psychological, Therapeutic counselling/listening

2.9

9.8

196

J02AC02

ATC

itraconazole; systemic

1.4

9.8

541

4058

F22.0

ICD-10 Finland

Delusional disorder

3.1

9.8

175

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.1

9.8

175

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

9.8

354

S22

ICPC

Nail symptom/complaint

1.8

9.8

177

1023

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

9.8

435

3140

ZXC10

NOMESCO Finland

Use of laser

2.4

9.8

336

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

9.8

145

785

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

5.9

9.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

9.8

281

1847

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

9.8

347

2391

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

9.8

208

1265

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.4

9.8

337

F43.00

ICD-10 Finland

Acute stress reaction mild

2.3

9.8

364

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.9

9.8

131

686

S16

ICPC

Bruise/contusion

2.3

9.8

408

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

9.7

319

H16.0

ICD-10 Finland

Corneal ulcer

1.9

9.7

145

789

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

9.7

1025

8462

F45.0

ICD-10 Finland

Somatization disorder

6.5

9.7

R25.2

ICD-10 Finland

Cramp and spasm

2.6

9.7

277

S82

ICPC

Naevus/mole

1.5

9.7

364

2541

N05AD03

ATC

melperone; systemic

3.3

9.7

139

R07.2

ICD-10 Finland

Precordial pain

2.7

9.6

229

K07.61

ICD-10 Finland

Cracking jaw joint

2.8

9.6

212

R01AX03

ATC

ipratropium bromide; nasal

2.6

9.6

253

C09CA03

ATC

valsartan; oral

1.6

9.6

244

1556

D01AE15

ATC

terbinafine; topical

1.7

9.6

205

1248

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

9.6

105

505

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.2

9.6

151

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

9.6

143

778

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

11.4

9.5

IGV01

NOMESCO Finland

Psychiatric network contact

4.5

9.5

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

4.5

9.5

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

9.5

135

721

A10BJ05

ATC

dulaglutide; parenteral

4.1

9.5

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

9.5

212

1306

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.8

9.5

202

A10BH02

ATC

vildagliptin; oral

2.6

9.5

249

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.9

9.5

139

752

A97

ICPC

No disease

1.4

9.5

456

3336

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

9.5

292

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

4.0

9.5

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

9.5

133

709

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.4

9.5

C02EA02

ATC

1.9

9.5

128

670

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.3

9.5

136

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

9.4

111

552

H92.0

ICD-10 Finland

Otalgia

1.8

9.4

146

804

G43.2

ICD-10 Finland

Status migrainosus

100.2

9.4

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.9

9.4

128

674

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.1

9.4

U01

ICPC

Dysuria/painful urination

1.7

9.4

191

1148

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.6

9.4

269

R28

ICPC

Limited function/disability (R)

3.5

9.4

121

A02BA03

ATC

famotidine; systemic

2.0

9.4

113

568

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.9

9.4

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

9.4

159

904

N80.9

ICD-10 Finland

Endometriosis, unspecified

3.0

9.4

170

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

+∞

9.4

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

9.4

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.9

9.4

G25.0

ICD-10 Finland

Essential tremor

2.4

9.4

325

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.8

9.3

199

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

9.3

239

1529

R31

ICD-10 Finland

Unspecified haematuria

1.5

9.3

301

2037

S06

ICPC

Rash localized

1.8

9.3

158

900

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

9.3

188

1129

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

9.3

116

591

A03

ICPC

Fever

1.4

9.3

491

3660

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

9.3

110

551

-31

ICPC

Medical examin/health eval partial

1.7

9.2

209

1291

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

9.2

135

731

L20.0

ICD-10 Finland

Besnier prurigo

1.7

9.2

199

1213

N05AH02

ATC

clozapine; systemic

2.4

9.2

302

A10BJ01

ATC

exenatide; parenteral

4.1

9.2

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.0

9.2

E86

ICD-10 Finland

Volume depletion

2.5

9.2

273

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.2

9.2

435

IEV99

NOMESCO Finland

Other psychiatric network intervention

6.0

9.2

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

9.2

116

595

N04BC04

ATC

ropinirole; oral

3.2

9.2

145

K80

ICPC

Cardiac arrhythmia NOS

1.7

9.2

200

1224

N05BB01

ATC

hydroxyzine; systemic

1.7

9.1

190

1150

F60.0

ICD-10 Finland

Paranoid personality disorder

6.7

9.1

SPAT1360

SPAT

Extensive global examination

1.6

9.1

208

1292

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

9.1

310

2120

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

9.1

129

690

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.8

9.1

147

825

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

9.1

241

1558

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

9.1

238

F06.7

ICD-10 Finland

Mild cognitive disorder

2.5

9.0

270

S02.51

ICD-10 Finland

Fracture of tooth, open

1.5

9.0

297

2015

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.7

9.0

100

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

9.0

105

521

Y94.8

ICD-10 Finland

Other leisure activity accident

2.2

9.0

393

J01MA06

ATC

norfloxacin; oral

1.4

9.0

366

2597

N05AF05

ATC

zuclopenthixol; systemic

3.1

8.9

148

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

8.9

313

N02CX04

ATC

2.9

8.9

181

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

8.9

130

703

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.3

8.9

354

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

8.9

138

763

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

3.1

8.9

154

P73

ICPC

Affective psychosis

6.1

8.9

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

4.3

8.9

C09CA07

ATC

telmisartan; oral

1.7

8.9

199

1228

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.3

8.9

335

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

5.5

8.9

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.5

8.9

290

1968

P02

ICPC

Acute stress reaction

2.0

8.9

115

595

7807A

ICD-9 Finland

General symptoms, Malaise and fatigue

7.9

8.8

F90.9

ICD-10 Finland

Hyperkinetic disorder, unspecified

7.9

8.8

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

8.8

133

726

G01AF05

ATC

econazole; vaginal

1.6

8.8

197

1216

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

8.8

308

2119

A08

ICPC

Swelling

2.0

8.8

106

534

U05

ICPC

Urination problems other

1.9

8.8

129

700

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.0

8.8

108

548

S76

ICPC

Skin infection other

1.8

8.8

140

779

F60.7

ICD-10 Finland

Dependent personality disorder

6.3

8.8

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

9.5

8.8

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

4.6

8.8

S99.9

ICD-10 Finland

Unspecified injury of ankle and foot

2.4

8.7

311

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.2

8.7

134

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

8.7

151

864

R44.1

ICD-10 Finland

Visual hallucinations

5.6

8.7

M54.1

ICD-10 Finland

Radiculopathy

2.0

8.7

112

578

SPAT1131

SPAT

Colonoscopy

2.1

8.7

464

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.9

8.7

171

C10AC01

ATC

colestyramine; oral

2.3

8.7

340

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

8.7

189

1160

L18

ICPC

Muscle pain

2.0

8.7

110

567

R09

ICPC

Sinus symptom/complaint

1.6

8.6

208

1308

N48.1

ICD-10 Finland

Balanoposthitis

2.2

8.6

366

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.7

8.6

209

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

8.6

330

2311

N04BB01

ATC

amantadine; oral

2.9

8.6

180

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

8.6

313

2172

E000002

ATC

1.5

8.6

338

2384

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.9

8.6

174

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.5

8.6

332

2333

WZC00

SPAT

1.8

8.6

137

766

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

8.2

8.6

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

8.5

160

937

S10

ICPC

Boil/carbuncle

1.7

8.5

160

937

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

8.5

226

1459

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.5

290

1984

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

8.5

153

889

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.0

8.5

154

P18

ICPC

Medication abuse

4.9

8.5

M01AX01

ATC

nabumetone; oral

1.9

8.5

126

684

ZXC84

NOMESCO Finland

Bloodless operation space

4.2

8.5

A99

ICPC

Disease/condition unspecnature/site

1.6

8.5

216

1383

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.4

8.5

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.4

8.5

116

G04BD11

ATC

fesoterodine; oral

2.2

8.5

409

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.4

8.4

285

XCK00

NOMESCO Finland

Perimetry

1.7

8.4

178

1082

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

8.4

148

850

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

8.4

105

535

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

8.4

122

660

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

8.4

418

3077

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

8.4

258

1727

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

8.4

256

1708

H50.52

ICD-10 Finland

Exophoria

3.4

8.4

112

L84

ICPC

Back syndrome without radiat pain

1.9

8.3

123

667

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.8

8.3

133

743

3468X

ICD-9 Finland

Migraine, Other forms of migraine

+∞

8.3

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

+∞

8.3

315

Kela drug reimbursment

Clopidogrel

4.0

8.3

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.5

8.3

102

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

8.3

165

986

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

8.3

219

N06BA09

ATC

atomoxetine; oral

8.5

8.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

8.3

234

1535

R20.1

ICD-10 Finland

Hypoaesthesia of skin

4.6

8.3

W17

ICD-10 Finland

Other fall from one level to another

1.8

8.3

140

798

E03

ICD-10 Finland

Other hypothyroidism

1.8

8.3

140

798

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.1

8.3

443

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

8.3

104

533

R19.4

ICD-10 Finland

Change in bowel habit

2.3

8.2

310

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

7.1

8.2

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

8.2

181

1113

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

8.2

483

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

8.2

248

1652

L10

ICPC

Elbow symptom/complaint

1.8

8.2

133

747

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.5

8.1

277

1896

SPAT1285

SPAT

Provision of consultation response

1.7

8.1

160

955

D93

ICPC

Irritable bowel syndrome

3.3

8.1

120

H53.2

ICD-10 Finland

Diplopia

2.2

8.1

371

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.0

8.1

490

N19

ICD-10 Finland

Unspecified kidney failure

2.0

8.1

454

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.8

8.1

127

706

S04

ICPC

Lump/swelling localized

1.5

8.1

269

1834

C01BC04

ATC

flecainide; systemic

2.0

8.1

495

R06AX26

ATC

fexofenadine; oral

1.6

8.0

197

1247

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

8.0

756

6134

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

8.0

287

1982

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.7

8.0

201

F45.1

ICD-10 Finland

Undifferentiated somatoform disorder

8.9

8.0

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

8.0

172

1050

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

3.2

8.0

127

358

Kela drug reimbursment

liraglutide

6.3

8.0

K92.1

ICD-10 Finland

Melaena

1.8

8.0

139

798

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.6

8.0

190

1195

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

2.3

8.0

294

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.4

8.0

106

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.2

8.0

335

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

4.1

7.9

F50.8

ICD-10 Finland

Other eating disorders

7.2

7.9

C07AG02

ATC

carvedilol; oral

1.7

7.9

170

1040

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.7

7.9

M01AE51

ATC

ibuprofen, combinations; systemic

2.7

7.9

197

R04.0

ICD-10 Finland

Epistaxis

1.6

7.9

197

1253

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

7.9

125

698

SPAT1359

SPAT

Use of symptom diary

2.3

7.9

318

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

7.8

111

593

S03.0

ICD-10 Finland

Dislocation of jaw

4.5

7.8

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.5

7.8

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

5.7

7.8

R03DC01

ATC

zafirlukast; oral

2.6

7.8

199

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.5

7.8

264

1805

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

7.8

160

966

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.6

7.8

S02

ICPC

Pruritus

2.0

7.8

488

R4120

SPAT

10.8

7.8

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

7.8

180

1126

R10.0

ICD-10 Finland

Acute abdomen

2.0

7.8

463

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.8

7.7

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3711

27747

2.49

151.38

4.9

3.6

14.7

pmol/l

0.79

3467

25259

(3030981) Hyaline casts [#/volume] in Urine by Automated count

578

1855

3.41

145.25

3.6

2.8

0.3

e6/l

0.35

568

1807

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1682

9431

2.21

136.47

2.4

2.0

203.2

242.8

u/l

0.66

1586

8810

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1385

7178

2.31

136.05

1.8

1.6

9475872.6

24834965.4

pmol/l

1.07

1182

6044

(3013707) Erythrocyte sedimentation rate by Westergren method

3586

26956

2.31

135.31

5.0

3.7

11.5

11.6

mm/h

0.22

3388

24937

(3036481) Cortisol [Moles/volume] in Serum or Plasma

731

2853

2.84

130.30

2.2

357.3

379.0

nmol/l

2.26

677

2622

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2375

15402

2.07

129.74

6.7

6.0

1.2

mmol/l

1.55

2179

14014

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3678

28160

2.32

129.26

8.2

7.5

77.5

78.3

u/l

0.43

3537

26556

(3019309) Folate [Moles/volume] in Red Blood Cells

1195

5925

2.35

129.25

1.8

1.7

1256.1

1153.1

nmol/l

3.28

957

4488

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2563

17140

2.06

128.16

7.9

6.7

1.2

mmol/l

1.80

2182

14556

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2032

12525

2.08

126.51

4.7

3.1

76.3

93.7

ng/l

0.13

1310

8275

(3013826) Glucose [Moles/volume] in Serum or Plasma

2954

20917

2.07

124.92

5.6

4.5

6.7

mmol/l

0.40

2792

19417

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1829

10912

2.09

123.63

3.1

2.5

53.9

59.0

u/l

5.59

1713

10108

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2215

14181

2.04

123.37

2.7

2.2

77.3

76.4

nmol/l

0.73

2071

12841

(3019150) Specific gravity of Urine by Refractometry

1421

7746

2.19

121.07

4.3

3.6

1.0

kg/l

0.62

191

1171

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

503

1656

3.28

120.46

4.1

4.2

1.8

1.9

mmol/l

0.13

361

1196

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

520

1753

3.21

119.71

4.3

4.2

5.2

5.1

kpa

3.09

491

1613

(3009343) pH of Capillary blood

514

1725

3.22

119.21

4.2

7.4

1.54

227

(3029937) Albumin [Presence] in Urine by Test strip

1632

9537

2.08

114.77

4.5

3.6

0.0

estimate

1.94

505

3176

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1574

9091

2.09

114.11

3.4

2.9

1273.8

1561.1

ng/l

1.54

1331

7826

(3015377) Calcium [Moles/volume] in Serum or Plasma

1867

11485

2.02

113.71

3.0

3.5

2.3

2.4

mmol/l

2.02

1690

10121

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4142

34061

2.59

113.06

5.9

4.2

2.4

2.2

mu/l

0.11

3890

31181

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2144

13896

1.98

112.03

2.2

1.9

98.5

94.3

pmol/l

3.59

1205

7403

(3021601) Nitrite [Presence] in Urine by Test strip

2567

17919

1.93

105.44

5.7

4.5

0.0

estimate

0.80

527

3313

(3009261) Glucose [Presence] in Urine by Test strip

2588

18123

1.93

105.19

4.4

3.3

0.0

estimate

0.25

496

3228

(3035350) Ketones [Presence] in Urine by Test strip

2562

17898

1.93

104.71

4.3

3.3

0.0

estimate

1.34

481

3245

(3024561) Albumin [Mass/volume] in Serum or Plasma

2265

15215

1.93

104.02

5.2

5.1

35.6

35.5

g/l

0.33

2120

14156

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2322

15759

1.92

103.03

3.6

2.7

113.1

134.6

ug/l

5.72

2194

14674

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2094

13851

1.91

99.38

4.5

3.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1892

12105

1.93

99.36

3.6

3.2

32.8

36.1

u/l

0.45

1795

11499

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2601

18493

1.89

98.24

6.0

6.4

10.9

11.9

umol/l

3.18

2480

17603

(3031040) Bacteria [#/volume] in Urine by Automated count

3168

24026

1.94

97.89

5.8

3.9

337.6

1964.6

e6/l

2.47

211

313

(3022313) Gas panel - Capillary blood

377

1192

3.35

95.82

4.2

4.6

—

(3013115) Eosinophils [#/volume] in Blood

2642

19072

1.86

93.08

6.5

6.1

0.2

e9/l

1.81

2384

16736

(3021960) Folate [Moles/volume] in Serum or Plasma

1340

7762

2.01

92.89

1.7

1.5

20.8

20.0

nmol/l

0.87

1199

6672

(3041096) Erythrocytes [Presence] in Urine by Automated

1594

9832

1.93

91.76

4.0

3.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3278

25404

1.92

91.60

5.2

3.9

—

(3032080) INR in Blood by Coagulation assay

2063

13920

1.85

89.04

10.5

8.4

1.2

1.3

inr

0.68

628

3965

(3019198) Lymphocytes [#/volume] in Blood

2597

19010

1.80

83.75

6.5

5.9

2.0

1.9

e9/l

0.66

2354

16755

(3001604) Monocytes [#/volume] in Blood

2533

18412

1.80

83.58

6.3

5.9

0.6

e9/l

0.01

2262

15890

(3006315) Basophils [#/volume] in Blood

2537

18471

1.79

83.04

6.4

5.9

0.0

e9/l

0.63

2267

15959

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3222

25247

1.84

81.88

3.9

2.9

48.4

46.8

u/l

0.46

3049

23605

(3040151) Glucose [Moles/volume] in Capillary blood

169

333

5.22

81.15

50.8

7.0

7.9

7.1

mmol/l

1.76

139

288

(3022948) Iron [Moles/volume] in Serum or Plasma

1002

5483

2.05

79.78

2.8

2.5

13.6

13.4

umol/l

0.55

944

5104

(3018095) Leukocytes [#/volume] in Urine

1912

12914

1.80

79.72

4.8

3.6

65.7

96.1

e6/l

1.36

1506

9036

(3002582) Erythrocytes [#/volume] in Urine

1687

11033

1.82

77.89

3.9

3.2

40.1

94.1

e6/l

2.84

1400

8412

(3000850) Epithelial cells [#/volume] in Urine

1254

7506

1.91

76.54

3.2

2.5

5.5

5.4

e6/l

0.15

1077

6544

(3004789) Transferrin [Mass/volume] in Serum or Plasma

938

5084

2.05

76.31

2.8

2.5

2.4

2.3

g/l

7.88

883

4719

(3022096) Basophils/100 leukocytes in Blood

2325

16784

1.75

75.76

6.5

6.2

0.6

0.7

1.57

2187

15701

(3019069) Monocytes/100 leukocytes in Blood

2390

17437

1.74

74.56

6.8

6.3

8.5

8.6

2.08

2261

16378

(3051387) C reactive protein [Mass/volume] in Capillary blood

266

790

3.51

74.31

4.4

3.1

24.8

27.2

mg/l

0.47

205

497

(3018418) pH of Serum or Plasma

1557

10054

1.81

74.19

4.3

4.1

7.4

0.06

307

1831

(3006504) Eosinophils/100 leukocytes in Blood

2376

17331

1.74

73.96

6.5

6.1

2.9

0.99

2238

16183

(3015235) Bicarbonate [Moles/volume] in Capillary blood

261

768

3.54

73.95

4.4

3.4

25.0

24.6

mmol/l

0.69

240

675

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

876

4684

2.06

73.70

2.1

1.8

1.5

1.4

0.19

805

4157

(3026782) Osmolality of Urine

1177

6980

1.91

73.45

3.3

2.7

555.6

562.3

mosm/kgh2o

0.45

1007

5901

(3002030) Lymphocytes/100 leukocytes in Blood

2441

18007

1.72

72.36

6.6

6.1

28.2

28.0

0.21

2305

16820

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4204

36534

2.23

72.30

5.4

4.1

6.0

5.9

mmol/l

8.26

3930

33435

(3018010) Neutrophils/100 leukocytes in Blood

2411

17729

1.72

72.27

6.4

5.9

57.4

57.2

0.34

2282

16623

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4004

34191

2.04

71.81

7.5

5.2

40.9

39.2

mmol/mol

16.48

3772

31726

(3009508) Creatinine [Moles/volume] in Urine

1656

11016

1.77

70.55

3.6

3.2

7.9

7.8

mmol/l

0.64

1425

9362

(3013650) Neutrophils [#/volume] in Blood by Automated count

2790

21483

1.71

69.50

9.2

9.3

4.2

4.1

e9/l

0.94

2521

18754

(3019550) Sodium [Moles/volume] in Serum or Plasma

4391

39037

2.49

68.54

21.7

14.3

139.7

mmol/l

0.00

4324

37962

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1382

8794

1.80

67.99

2.5

2.1

3.0

2.9

mg/l

1.72

1228

7537

(1002224) Polysomnography panel

300

1017

3.08

67.47

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1261

7830

1.83

67.14

1.4

1.3

1.5

2.3

u/ml

1.52

430

2099

(40768797) Stomach Pathology biopsy report

847

4637

2.00

66.08

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4393

39180

2.45

65.98

21.8

14.5

4.0

mmol/l

0.16

4316

38027

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4322

38298

2.31

65.60

19.3

12.7

20.5

24.8

mg/l

15.71

3699

29686

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

853

4737

1.97

63.66

2.9

2.6

23.0

23.6

0.69

736

4088

(3037522) Nuclear Ab [Titer] in Serum

843

4700

1.96

62.05

1.4

1.3

486.0

512.4

titre

0.15

154

974

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

988

5813

1.88

61.79

1.4

1.2

20.8

32.9

iu/ml

4.74

265

1852

(3044889) 12 lead EKG panel

3182

25825

1.69

61.02

4.4

3.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

957

5596

1.89

60.91

3.1

3.5

0.8

mmol/l

1.86

879

5242

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1199

7549

1.78

59.86

1.7

0.9

1.3

mg/l

7.78

900

5767

(3026008) Bacteria identified in Urine by Culture

1477

9914

1.71

58.52

3.5

2.8

—

(3048689) Calprotectin [Mass/mass] in Stool

781

4325

1.96

58.32

2.2

2.5

120.2

138.5

ug/g

0.71

611

3452

(3028707) Methadone [Presence] in Urine by Screen method

209

626

3.45

57.52

3.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

922

5426

1.87

57.12

1.4

1.2

16.0

12.9

u/ml

0.23

384

2154

(3003458) Phosphate [Moles/volume] in Serum or Plasma

798

4496

1.93

56.47

6.4

6.3

1.0

mmol/l

0.12

738

4205

(42870588) Differential panel, method unspecified - Blood

1739

12302

1.65

55.75

5.9

6.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

145

349

4.25

54.55

6.3

5.8

377.9

371.5

umol/l

0.20

133

296

(3020682) Albumin/Creatinine [Ratio] in Urine

1545

10669

1.66

54.06

4.4

4.0

9.5

9.6

mg/mmol

0.03

1057

6881

(3021901) Oxygen saturation in Capillary blood

191

564

3.49

53.72

3.2

3.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1264

8307

1.71

53.20

4.8

4.5

—

(3013512) EKG study

1424

9772

1.65

50.31

4.6

3.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1383

9427

1.66

50.14

2.9

2.6

2760.7

4902.5

umol/l

1.53

1206

8273

(3028626) Oxygen [Partial pressure] in Capillary blood

222

753

3.04

49.74

4.6

3.7

8.2

kpa

0.01

211

697

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

271

1025

2.74

49.73

4.5

4.7

24.6

mmol/l

0.02

258

937

(3008152) Bicarbonate [Moles/volume] in Arterial blood

437

2074

2.22

48.91

6.4

6.6

24.9

24.3

mmol/l

2.18

418

1919

(3023368) Bacteria identified in Blood by Culture

1379

9595

1.61

45.11

4.7

4.3

—

(3003396) Base excess in Arterial blood by calculation

669

3836

1.86

44.01

6.3

7.5

1.6

0.9

mmol/l

4.81

527

2970

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

206

718

2.95

43.97

1.2

1.3

422.5

545.8

mg/l

5.37

192

685

(3012516) Albumin [Mass/volume] in Urine

1430

10097

1.59

43.72

3.6

3.2

508.6

339.8

mg/l

0.61

954

6443

(3002385) Erythrocyte distribution width [Ratio]

3714

32428

1.65

43.56

22.7

15.7

13.7

13.6

1.01

3659

31696

(3000034) Microalbumin [Mass/volume] in Urine

128

333

3.92

43.37

3.2

3.3

71.9

35.8

mg/l

0.74

253

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

187

627

3.06

42.73

1.1

1.3

3.6

3.8

mmol/l

2.30

181

588

(3019060) Gas panel - Arterial blood

423

2092

2.12

42.47

4.6

—

(3016502) Oxygen saturation in Arterial blood

614

3476

1.88

41.92

6.4

7.9

94.2

95.8

4.36

596

3346

(3017181) Myelocytes/100 leukocytes in Blood

557

3060

1.93

41.67

3.9

4.3

0.8

0.9

0.58

154

867

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

410

2023

2.12

41.39

3.4

3.3

4.5

pmol/l

0.69

366

1799

(3021589) Normoblasts [#/volume] in Blood

2135

16620

1.51

41.35

10.9

9.1

0.0

e9/l

1.36

1821

13539

(3006184) Hemoglobin [Mass/volume] in Capillary blood

201

717

2.88

41.14

2.1

2.3

135.6

129.7

g/l

2.60

172

526

(3025159) Blasts/100 leukocytes in Blood

512

2745

1.97

41.13

4.0

4.3

0.0

0.4

1.41

125

663

(3007164) IgA [Mass/volume] in Serum or Plasma

1053

6989

1.65

41.06

1.6

1.5

2.4

2.5

g/l

0.22

691

4344

(3000570) Elastase.pancreatic [Mass/mass] in Stool

241

947

2.63

40.96

1.5

1.4

303.0

276.7

ug/g

1.07

147

565

(3018677) aPTT in Platelet poor plasma by Coagulation assay

807

4999

1.74

40.73

1.8

2.2

29.6

30.0

1.08

781

4838

(40761511) CBC panel - Blood by Automated count

4389

40380

2.03

40.72

18.7

11.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

533

2907

1.94

40.70

4.0

4.3

0.1

0.2

0.45

144

804

(4010399)

446

2286

2.05

40.65

1.4

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

205

4.61

39.16

11.3

11.9

0.6

mmol/l

0.10

190

(3015171) Extractable nuclear Ab [Units/volume] in Serum

289

1263

2.37

39.12

1.3

1.2

0.7

1.4

u/ml

0.79

119

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

180

623

2.96

38.91

1.3

1.4

3404.4

6730.3

e6/l

0.21

160

499

(3022145) Colonoscopy Study observation

661

3942

1.79

37.86

1.3

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4445

41239

2.07

37.80

12.5

9.5

28.6

26.4

u/l

2.18

4351

39747

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

178

624

2.92

37.61

1.2

1.3

29.7

28.2

e6/l

0.02

149

477

(3005322) IgE [Units/volume] in Serum or Plasma

410

2098

2.04

37.45

1.4

1.3

408.1

235.6

u/ml

0.32

383

1934

(3007853) Bacteria identified in Skin by Aerobe culture

682

4129

1.76

37.03

2.0

1.7

—

(1616796) Gas panel - Central venous blood

189

701

2.77

35.96

3.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

434

2300

1.98

35.88

2.4

37.2

21.9

au/ml

0.66

142

(3027801) Oxygen [Partial pressure] in Arterial blood

640

3856

1.76

35.22

6.5

7.5

11.2

12.6

kpa

10.71

611

3678

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

640

3858

1.76

35.16

6.5

7.5

5.2

5.1

kpa

3.33

611

3680

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.21

34.72

1.7

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.21

34.72

1.7

2.6

—

(3000494) Fungus identified in Specimen by Culture

673

4130

1.73

34.68

1.5

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

212

854

2.55

34.23

2.7

2.4

49.1

102.6

ug/min

2.52

143

521

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

917

6133

1.61

33.87

2.8

3.2

2.4

mmol/l

1.26

811

5385

(3002173) Hemoglobin [Mass/volume] in Arterial blood

549

3236

1.79

32.43

6.8

8.2

125.5

121.1

g/l

4.86

533

3111

(3025941) Bacteria identified in Stool by Culture

378

1979

1.99

32.27

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

522

3043

1.80

31.98

2.7

1.9

12.2

13.1

nmol/l

1.94

466

2703

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3981

36127

1.60

31.78

4.6

3.6

1.4

1.3

mmol/l

24.22

3746

33289

(3011288) Drugs identified in Urine by Screen method

238

1046

2.34

31.77

3.3

3.0

—

(3022689) Creatine [Moles/volume] in Urine

112

5.50

31.72

1.3

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

436

2417

1.88

31.38

1.8

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

171

4.50

31.24

1.8

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4183

38472

1.69

31.13

5.6

4.4

2.7

2.8

mmol/l

8.72

3941

35590

(3021387) Prolactin [Units/volume] in Serum or Plasma

275

1296

2.19

31.06

1.7

1.6

348.7

307.0

mu/l

0.74

251

1170

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3962

35996

1.58

30.56

17.4

12.0

83.2

82.9

ml/min/173m2

0.32

3200

29388

(1001926) Buprenorphine [Presence] in Urine by Screen method

262

1221

2.21

30.42

3.1

2.2

—

(3019977) pH of Arterial blood

183

4.32

30.42

1.9

2.7

7.4

0.47

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

186

748

2.55

30.14

2.4

1.8

188.6

212.6

pmol/l

2.22

176

702

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

133

4.94

29.96

2.4

2.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

862

5833

1.58

29.91

3.3

2.9

2.8

2.1

e6/l

1.25

542

3195

(3027945) Reticulocytes/100 erythrocytes in Blood

625

3919

1.68

29.44

3.1

2.6

1.7

0.07

569

3498

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

949

6589

1.55

29.34

4.4

3.5

268.7

512.4

ng/l

1.10

675

5134

(40758558) Short blood count panel - Blood

1266

9368

1.48

28.78

6.5

7.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4087

37529

1.60

28.71

5.0

4.0

1.4

1.5

mmol/l

9.60

3852

34763

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4110

37799

1.61

28.59

5.2

4.0

4.5

4.7

mmol/l

13.99

3890

35180

(3022217) INR in Platelet poor plasma by Coagulation assay

685

4436

1.63

28.39

22.1

23.7

1.3

inr

0.05

646

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

425

2410

1.84

28.39

4.3

4.1

96.1

91.4

ng/l

0.48

367

2106

(3018405) Lactate [Moles/volume] in Arterial blood

248

1175

2.17

27.63

3.3

3.9

1.4

mmol/l

0.02

241

1156

(3020779) Urea [Moles/volume] in Serum or Plasma

530

3239

1.72

27.36

8.3

7.7

10.1

9.8

mmol/l

0.30

504

3099

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

379

2103

1.87

27.10

1.3

79.6

52.4

au/ml

—

100

(3042936) Bacteria identified in Isolate by Culture

762

5137

1.57

26.58

2.2

2.0

—

(3010421) pH of Blood

189

815

2.37

26.35

4.9

4.0

7.4

0.40

159

678

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

157

4.31

26.21

1.1

1.9

8.2

nmol/l

1.35

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

9.73

25.88

2.4

25.2

umol/l

0.00

(3030467) Casts [#/volume] in Urine by Automated count

1326

10090

1.43

25.44

3.6

3.1

0.3

0.4

e6/l

3.04

1037

7534

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1253

9439

1.44

25.38

1.8

1.6

1.5

1.4

mmol/l

3.96

1079

8040

(44816559) Phosphatidylethanol [Mass/volume] in Blood

164

676

2.48

25.26

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

464

2795

1.73

25.16

3.5

4.1

0.5

0.6

0.49

619

(3016879) Cocaine [Presence] in Urine

286

1482

1.99

25.06

2.8

2.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

448

2688

1.74

24.62

2.4

2.8

10.2

10.6

g/l

1.05

410

2456

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

8.25

24.36

2.0

2.1

14.7

17.7

umol/l

0.70

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

236

3.52

24.11

2.0

2.3

19.3

18.5

nmol/l

0.28

224

(36304419) Bacteria [Presence] in Urine

1286

9830

1.42

23.75

3.5

3.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

211

1000

2.16

23.50

1.4

8.9

10.0

u/l

0.73

170

802

(3012501) Base excess in Blood by calculation

162

688

2.40

23.40

5.0

4.1

2.6

2.7

mmol/l

0.09

118

454

(3044290) Cell count panel - Cerebral spinal fluid

143

583

2.50

22.58

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

296

1613

1.89

22.34

2.8

2.0

—

(3045424) Erythrocytes [Presence] in Urine

141

575

2.50

22.25

1.6

1.5

—

(3028300) Cannabinoids [Presence] in Urine

296

1616

1.89

22.21

3.0

2.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

207

997

2.12

22.13

3.4

4.1

3.8

3.9

mmol/l

0.80

156

933

(3000764) Benzodiazepines [Presence] in Urine

293

1599

1.89

22.01

2.9

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

382

2261

1.75

21.97

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

228

1146

2.04

21.76

2.0

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

259

1362

1.95

21.75

1.8

1.7

3.0

3.5

mg/l

0.78

225

903

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

770

5427

1.50

21.51

2.1

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

349

2026

1.78

21.46

1.8

1.4

—

(3027944) Amphetamines [Presence] in Urine

289

1588

1.87

21.25

2.9

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2107

17683

1.34

21.17

4.5

4.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

393

2370

1.72

21.13

1.3

1.2

81.0

162.6

iu/ml

5.73

153

852

(3021447) Carbon dioxide [Partial pressure] in Venous blood

509

3284

1.62

21.08

4.5

3.9

6.0

5.8

kpa

3.91

487

3184

(3020961) Endomysium IgA Ab [Titer] in Serum

300

1673

1.85

21.05

1.2

1.1

50.0

171.3

titre

2.39

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

546

3622

1.57

20.07

3.8

3.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

651

4491

1.52

20.04

6.3

7.3

104.2

104.6

mmol/l

1.10

589

4400

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

322

1870

1.77

19.75

1.0

—

(3002032) Base excess in Venous blood by calculation

501

3270

1.59

19.73

4.5

3.9

2.1

1.8

mmol/l

1.43

412

2605

(3044640) Blood type and Crossmatch panel - Blood

1466

11740

1.36

19.70

2.4

—

(40768804) Tissue Pathology biopsy report

1811

14975

1.34

19.66

2.2

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

425

2672

1.65

19.49

3.8

3.2

4.8

4.6

kpa

0.71

406

2584

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

253

1376

1.89

19.21

2.1

1.9

1.3

2.9

ug/l

1.98

226

1216

(3032773) Endomysium IgG Ab [Titer] in Serum

332

2.84

19.15

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

114

452

2.56

19.13

1.3

—

(1761868) Lipid panel - Serum or Plasma

1695

13958

1.33

18.66

3.4

2.6

—

(40767503) Oxygen content in Capillary blood by calculation

148

672

2.24

18.38

2.9

2.5

17.0

16.2

1.71

345

(3023183) Ammonium ion [Moles/volume] in Plasma

155

720

2.19

18.21

2.6

2.8

32.5

35.1

umol/l

0.54

129

613

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

261

1463

1.83

18.02

2.5

1.8

41.3

39.3

u/l

0.88

238

1289

(3022621) pH of Urine by Test strip

380

2370

1.66

17.95

3.1

2.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

427

2745

1.61

17.87

4.4

3.9

1.2

mmol/l

0.13

378

2396

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

182

914

2.03

17.45

1.3

1.2

18.4

33.9

u/ml

0.44

(4198724)

165

3.55

17.44

2.8

3.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

362

2248

1.66

17.39

2.0

2.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

278

1606

1.78

17.36

4.5

3.3

25.5

25.0

mmol/l

1.67

264

1550

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2823

25093

1.30

17.25

3.3

3.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

902

6804

1.40

17.17

1.7

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

237

3.07

17.16

1.1

1.0

250.2

287.3

mg/l

0.75

203

(3020630) Protein [Mass/volume] in Serum or Plasma

428

2785

1.59

17.00

2.2

2.7

66.2

66.4

g/l

0.22

383

2550

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

249

3.00

16.98

1.2

1.1

41.3

46.1

mg/l

0.26

202

(3035637) Corticotropin [Mass/volume] in Plasma

100

396

2.56

16.87

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

544

3745

1.51

16.77

1.9

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

192

3.26

16.36

1.3

3.2

—

(3007461) Platelets [#/volume] in Blood

4534

43621

1.73

16.31

28.4

18.6

250.2

249.3

e9/l

0.44

4466

42415

(3042517) Benzodiazepines panel - Urine

7.45

16.10

4.3

2.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

275

1623

1.74

15.95

1.5

1.3

22.7

28.4

iu/l

2.09

230

1380

(3035941) MCH [Entitic mass]

4534

43648

1.72

15.91

28.2

18.5

30.3

1.37

4494

43011

(3024731) MCV [Entitic volume]

4534

43652

1.72

15.85

28.3

18.5

90.7

90.9

1.73

4494

43015

(4027681)

181

3.29

15.82

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

415

2727

1.57

15.79

3.0

2.7

182.8

206.2

ng/l

0.36

365

2481

(3010813) Leukocytes [#/volume] in Blood

4535

43669

1.72

15.77

28.4

18.6

6.9

6.7

e9/l

5.23

4458

42329

(3026361) Erythrocytes [#/volume] in Blood

4534

43657

1.71

15.77

28.4

18.6

4.5

e12/l

2.55

4458

42341

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

430

2854

1.56

15.65

2.7

2.2

5.9

8.3

ug/l

2.53

357

2530

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

241

1377

1.79

15.64

5.4

4.6

1.8

1.6

1.22

231

1280

(3000963) Hemoglobin [Mass/volume] in Blood

4534

43670

1.71

15.58

28.5

18.7

136.8

136.3

g/l

1.29

4492

43029

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

539

3763

1.49

15.47

2.0

1.7

—

(3020891) Body temperature

231

1308

1.80

15.45

4.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

562

3962

1.47

15.35

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

298

2.71

15.28

1.2

1.4

12.4

12.3

mmol/l

0.01

(3047181) Lactate [Moles/volume] in Blood

194

1044

1.89

15.26

6.1

5.5

1.3

1.2

mmol/l

0.87

175

903

(3028026) IgM [Mass/volume] in Serum or Plasma

337

2124

1.63

15.26

1.9

2.0

1.2

1.4

g/l

1.82

309

1933

(3004119) Hemoglobin [Mass/volume] in Venous blood

333

2102

1.63

14.98

3.8

3.2

130.3

128.7

g/l

0.68

320

2051

(3023410) Appearance of Cerebral spinal fluid

273

2.78

14.97

1.4

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

166

855

1.98

14.87

1.3

3.0

5.5

u/ml

1.10

140

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

164

845

1.97

14.68

1.3

4.0

3.3

u/ml

0.12

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

140

682

2.08

14.63

1.3

1.2

24.3

33.6

u/ml

0.49

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

180

959

1.91

14.61

1.4

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

143

708

2.05

14.31

1.8

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

181

977

1.89

14.12

1.4

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

231

1363

1.73

13.44

5.5

4.7

0.9

0.37

222

1270

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

188

1048

1.83

13.27

1.8

1.6

1.2

g/l

1.45

177

992

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

235

2.79

13.19

1.4

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

230

2.81

13.13

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1684

14342

1.27

13.07

5.0

4.8

2.3

3.1

ug/l

2.65

1531

12937

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

182

1010

1.83

13.04

1.9

1.6

0.2

g/l

0.30

172

956

(3023419) Bacteria identified in Sputum by Culture

372

2.39

13.00

2.9

2.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

198

1130

1.78

12.94

2.8

2.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

255

2.69

12.88

1.7

1.3

1.7

1.4

promille

1.00

200

(36660697) Celiac disease serology panel - Serum

409

2800

1.50

12.86

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

447

3125

1.47

12.67

6.4

7.3

1.4

1.3

mmol/l

0.46

410

3012

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

183

1029

1.81

12.57

1.9

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

570

4182

1.41

12.46

2.7

2.9

6.5

8.7

umol/l

2.75

471

3667

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

177

990

1.82

12.38

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

172

954

1.83

12.36

1.1

2.4

6.4

u/ml

1.57

133

(3014765) Yersinia sp identified in Stool by Organism specific culture

178

999

1.81

12.31

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

148

3.20

12.16

1.3

1.2

140.6

134.2

nmol/l

0.36

148

(3008898) HLA-B27 [Presence]

210

1245

1.72

12.04

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

944

7539

1.31

11.92

2.1

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.02

11.88

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

177

1005

1.79

11.80

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

566

4189

1.40

11.73

2.2

2.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

189

2.88

11.67

3.4

2.6

227.2

198.1

u/l

0.81

189

(1761482) Bacteria [#/volume] in Urine by Culture

163

907

1.83

11.62

4.2

3.8

—

(3000991) Gas panel - Venous blood

426

3006

1.46

11.50

7.7

8.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

140

748

1.90

11.34

2.0

0.8

nmol/l

0.58

119

634

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

617

4663

1.37

11.25

2.3

2.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1027

8358

1.29

11.17

4.1

3.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

118

599

1.99

11.11

3.3

3.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

132

3.20

10.93

1.6

1.7

1.9

umol/l

0.03

123

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

141

766

1.87

10.87

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

606

4596

1.36

10.79

1.8

1.6

—

(44813793)

234

2.58

10.58

1.1

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

229

2.60

10.51

1.5

1.2

—

(40761536) Microorganisms panel - Urine sediment

423

3034

1.43

10.46

4.5

3.6

—

(3016018) Differential panel - Cerebral spinal fluid

308

2.36

10.44

1.2

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

237

1506

1.60

10.42

1.4

1.6

6.0

13.9

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

201

1228

1.66

10.34

1.3

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

243

1561

1.59

10.22

3.1

2.7

0.7

0.78

232

1496

(3027923) C peptide [Moles/volume] in Serum or Plasma

161

2.88

9.99

1.3

1.4

1.1

nmol/l

0.18

130

(3003181) Sodium [Moles/volume] in Urine

102

512

2.01

9.95

1.3

58.9

65.9

mmol/l

0.99

404

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

135

3.05

9.91

1.6

1.7

2.6

7.7

nmol/l

0.79

111

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

219

2.58

9.85

1.0

779.7

737.9

ng/l

0.23

149

(3011985) Renin [Units/volume] in Plasma

394

2.15

9.81

1.6

1.5

62.7

58.3

mu/l

0.11

346

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

102

515

2.00

9.80

1.4

1.3

7.1

7.2

mmol/l

0.17

379

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

175

1047

1.70

9.76

1.8

1.7

—

(3024263) Appearance of Synovial fluid

192

2.67

9.68

2.0

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

221

2.55

9.68

1.0

41.5

44.2

ng/l

0.22

157

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

165

2.81

9.57

3.6

3.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

385

2.15

9.56

1.9

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

1106

9237

1.26

9.54

4.0

90.7

89.5

0.90

1065

9018

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

205

1287

1.62

9.50

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

773

6191

1.30

9.35

3.0

2.7

1.2

1.1

e6/l

0.45

448

3529

(3023511) Choriogonadotropin [Units/volume] in Urine

131

731

1.81

9.33

1.5

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.89

9.30

1.3

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

191

1185

1.64

9.29

1.7

1.6

69.6

305.3

titre

1.77

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

220

2.52

9.26

1.0

333.8

326.2

ng/l

0.06

156

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

146

2.89

9.26

2.2

1.5

86.5

150.1

umol/l

0.96

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

157

927

1.72

9.21

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

2.97

9.02

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

133

754

1.79

9.00

1.2

1.3

259.5

259.4

u/ml

0.00

471

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

156

927

1.71

8.95

2.1

1.9

10.4

11.2

mg/l

0.74

148

863

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

6.68

8.89

1.7

1.6

2.7

2.0

mg/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

138

794

1.76

8.88

1.4

1.5

—

(3000492) Spirometry study

460

3446

1.37

8.81

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

136

782

1.76

8.78

2.4

4.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

169

1032

1.66

8.77

2.2

3.8

46.1

61.0

mg/l

0.84

129

844

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

233

2.42

8.70

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.86

8.67

1.2

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

203

1302

1.58

8.64

1.7

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

203

1302

1.58

8.64

1.7

2.3

7.6

7.4

g/l

0.37

121

994

(40761535) Cells panel - Urine sediment

389

2848

1.40

8.56

4.0

3.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

168

1033

1.65

8.50

2.3

3.8

35.5

64.3

mg/l

1.32

127

849

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

202

1300

1.58

8.48

1.7

2.3

3.9

g/l

0.06

115

951

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

450

3383

1.36

8.43

2.1

2.3

0.2

g/l

0.72

413

3140

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

122

688

1.79

8.43

1.4

1.2

1.3

5.6

u/ml

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

180

1129

1.62

8.41

2.0

2.5

759.9

638.4

ug/l

0.14

167

1071

(3039000) Anion gap in Blood

128

734

1.76

8.36

7.3

6.4

10.8

11.3

mmol/l

1.24

119

648

(3018572) Chloride [Moles/volume] in Blood

128

735

1.76

8.32

7.4

6.4

106.0

105.0

mmol/l

1.56

119

649

(3045414) Leukocytes [Presence] in Urine

243

1637

1.51

8.30

1.8

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

356

2582

1.41

8.28

2.4

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

254

1732

1.49

8.19

2.5

2.3

—

(3052851) Hemolysis interference index of Serum or Plasma

167

1036

1.63

8.17

2.5

3.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1335

11539

1.22

8.15

5.2

4.2

21.8

0.00

601

5684

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

228

2.38

8.15

1.1

1.3

0.1

1.3

u/ml

1.25

(3017569) Oxygen content in Arterial blood

157

2.69

8.14

2.1

2.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

190

1218

1.58

8.12

1.7

2.4

3.0

3.1

g/l

0.47

119

975

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

257

1761

1.49

8.09

5.2

4.3

24.6

24.0

mmol/l

2.78

220

1595

(3049717) Cytology report of Urine Cyto stain

211

1387

1.55

8.09

2.6

2.8

—

(3037756) Immunofixation for Serum or Plasma

121

690

1.77

8.07

1.4

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

136

803

1.71

8.03

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

215

1428

1.53

7.87

2.6

2.2

2439.3

5646.9

u/l

1.43

578

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

162

1012

1.62

7.73

2.3

3.7

1.4

3.4

ratio

0.84

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.60

7.56

1.0

—

(21494755) Public health laboratory ask at order entry panel

303

4154

0.71

7.51

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

170

2.54

7.48

1.3

1.2

4.5

5.2

umol/l

0.45

163

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

389

2.00

7.48

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

529

4146

1.31

7.46

2.9

4.6

234.5

246.1

u/l

1.22

499

3940

(3047007) Chlamydophila sp Ab [Presence] in Serum

495

1.88

7.44

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

173

1114

1.57

7.29

1.9

2.4

0.6

1.0

g/l

1.03

138

971

(4094501)

148

918

1.63

7.29

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

267

2.19

7.20

1.9

2.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

2.72

7.17

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

382

1.98

7.14

1.4

1.3

—

nmol/l

—

(4062490)

341

2.04

7.14

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

287

2059

1.42

7.13

2.2

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.44

7.10

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

269

1909

1.43

7.10

8.4

10.0

—

(3008295) Osmolality of Serum or Plasma

311

2.07

6.94

1.6

1.4

289.3

279.3

mosm/kgh2o

2.99

241

(3017732) Neutrophils [#/volume] in Blood

337

2497

1.38

6.93

3.9

2.9

4.1

4.2

e9/l

0.05

275

1978

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

445

3442

1.32

6.90

2.8

2.5

59.3

51.6

u/l

0.09

381

2979

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

122

731

1.69

6.88

1.4

1.5

96.6

122.2

u/ml

1.83

134

(3030905) Polymorphonuclear cells [#/volume] in Blood

116

686

1.71

6.87

3.1

3.5

4.2

4.0

e9/l

0.51

116

686

(3004716) Salmonella sp identified in Stool by Organism specific culture

269

1921

1.42

6.86

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

162

1043

1.57

6.86

3.4

3.8

1.6

1.5

mg/l

0.75

152

963

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

119

711

1.69

6.79

3.7

3.8

58.1

57.2

0.37

119

711

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

161

2.50

6.74

1.1

1.0

1.1

u/l

0.17

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

16.70

6.74

1.5

1.3

382.1

459.3

nmol/l

—

(3004809) Band form neutrophils/100 leukocytes in Blood

102

586

1.76

6.70

3.1

3.7

1.6

0.04

441

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

7.16

6.69

1.1

8.8

8.0

mmol/l

—

(40768443) Skin Pathology biopsy report

215

1479

1.47

6.69

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

282

2.11

6.69

1.1

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

174

1148

1.54

6.62

2.7

3.1

0.4

0.3

u/ml

0.71

623

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

153

988

1.57

6.42

1.5

2.2

0.0

g/l

0.87

130

910

(3008757) Leukocyte morphology finding [Identifier] in Blood

356

1.95

6.38

3.4

4.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

281

2.08

6.37

1.9

2.2

13.1

13.3

0.04

119

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.03

6.33

1.7

1.3

145.4

136.7

nmol/l

0.07

(3019225) pH of Specimen

424

3302

1.31

6.27

5.4

4.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

2.95

6.26

2.0

1.7

80.5

159.6

au/ml

—

(3037121) Protein [Mass/volume] in Urine

182

1229

1.50

6.23

3.5

3.4

0.3

0.4

g/l

0.82

549

(3004616) Nuclear Ab [Presence] in Serum

388

1.90

6.19

1.4

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

168

2.39

6.19

1.5

1.4

23.4

26.5

umol/l

0.24

159

(3023520) Reticulocytes [#/volume] in Blood

374

2868

1.33

6.17

2.6

2.7

72.2

68.0

e9/l

1.31

293

2169

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

531

4272

1.27

6.11

7.7

6.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

251

1810

1.41

6.10

8.4

10.2

24.7

24.2

mmol/l

1.97

223

1684

(3028192) IgG subclass 2 [Mass/volume] in Serum

342

1.94

6.04

1.4

2.8

2.9

g/l

0.27

250

(3022493) Free Hemoglobin [Mass/volume] in Plasma

134

2.55

6.02

1.3

5.6

77.0

62.2

mg/l

0.65

102

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

308

1.99

6.01

1.5

29.8

29.1

0.04

194

(3044927) Protein electrophoresis panel - Urine

309

1.99

5.96

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

372

1.89

5.96

1.3

315.8

279.2

pmol/l

0.30

278

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

474

1.79

5.91

1.4

19.4

25.7

u/l

1.33

407

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

186

2.27

5.79

1.2

1.5

7.0

6.7

u/l

0.06

163

(3004451) EKG impression Narrative

149

2.43

5.77

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

341

1.92

5.76

1.4

0.4

g/l

0.09

248

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.46

5.72

3.6

2.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

342

1.91

5.71

1.4

6.4

6.7

g/l

0.38

248

(3032057) Clostridioides difficile [Presence] in Stool

3.34

5.71

2.2

2.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

358

1.88

5.63

1.6

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

579

1.69

5.63

1.4

1.7

0.6

0.8

g/l

1.50

458

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

127

2.53

5.60

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

127

2.53

5.60

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

550

1.70

5.58

1.6

1.5

0.4

nmol/l

0.12

441

(3002256) Pathology report gross observation

600

4963

1.24

5.42

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

252

2.03

5.37

2.0

1.9

1.1

2.0

u/field

1.05

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

206

2.15

5.33

1.1

7.9

9.1

iu/ml

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

180

2533

0.70

5.24

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.83

5.24

1.3

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

123

796

1.56

5.19

1.5

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.48

5.17

1.1

0.6

0.7

umol/24h

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

586

1.65

5.15

1.1

114.2

16979.8

iu/ml

0.53

138

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

144

967

1.50

5.13

2.0

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

210

2.11

5.10

1.4

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

1224

1.45

5.09

1.8

2.3

9.8

10.2

g/l

0.76

130

1049

(3001729) Color of Synovial fluid

4.20

5.08

1.1

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

422

1.77

5.08

1.4

1.3

65.2

30.0

u/ml

—

(3006270) Folate [Moles/volume] in Blood

279

1.95

5.05

1.1

413.3

374.5

nmol/l

0.64

237

(3006245) CD3-CD19+ cells/100 cells in Blood

134

2.40

5.04

1.7

2.5

12.7

8.9

0.95

123

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

211

2.10

5.04

1.4

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

563

1.65

4.91

1.2

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

436

1.73

4.84

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

124

818

1.53

4.83

1.7

1.6

11173.5

12768.7

e6/l

0.24

581

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

131

2.38

4.80

1.7

2.4

27.1

29.6

0.54

121

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

536

1.65

4.79

1.3

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.59

4.78

1.1

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

295

3786

0.76

4.73

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

569

1.63

4.72

3.1

3.0

0.8

nmol/l

0.14

425

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.22

4.61

1.7

1.8

143.0

155.3

ng/l

0.13

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

512

1.65

4.58

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

119

788

1.52

4.57

4.9

5.7

432.3

3719.1

iu/ml

0.84

117

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

160

2.20

4.55

4.4

3.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

575

1.61

4.54

1.1

17.6

13.6

au/ml

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

121

806

1.51

4.53

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.77

4.53

1.1

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

214

2.02

4.50

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.86

4.48

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

618

1.58

4.43

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

373

1.75

4.42

2.6

2.0

35.6

22.0

mg/l

0.77

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.82

4.38

1.1

—

(3011412) CD3 cells [#/volume] in Blood

354

1.76

4.30

2.0

2.7

1.3

1.1

e9/l

1.10

213

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

438

1.68

4.25

1.5

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

439

1.67

4.22

1.5

1.6

—

(3024928) Oxygen saturation in Venous blood

114

763

1.51

4.20

3.2

3.1

—

(3030313) Adrenal Ab [Titer] in Serum

4.08

4.16

1.1

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

215

1617

1.35

4.14

1.4

1.8

1.5

g/l

0.13

180

1398

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

121

823

1.48

4.13

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

322

1.78

4.11

2.6

5.3

65.7

63.3

u/ml

0.02

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.71

4.08

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

437

1.66

4.03

1.5

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

253

1960

1.31

3.98

1.9

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

633

5427

1.19

3.97

1.5

—

(3017509) Phencyclidine [Presence] in Urine

3.43

3.90

1.1

1.8

—

(3036489) Thrombin time

172

1262

1.38

3.89

1.6

2.3

21.0

21.8

0.97

144

1103

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

129

901

1.44

3.87

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

450

1.63

3.87

1.5

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

143

1019

1.42

3.85

1.5

2.1

37.9

37.4

g/l

0.44

108

892

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

522

1.58

3.81

1.5

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

101

2.38

3.81

1.6

11.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

383

1.68

3.80

1.7

1.6

62.3

60.6

0.13

245

(4146454)

316

1.75

3.78

2.6

2.8

—

(3042631) Mycobacterium sp identified in Specimen

461

1.61

3.77

3.0

2.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

378

1.68

3.71

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

168

2.03

3.69

1.1

14.0

23.4

u/l

1.08

132

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

168

2.03

3.69

1.1

66.6

93.3

u/l

1.74

135

(3010144) Erythrocytes [#/volume] in Synovial fluid

304

1.75

3.67

1.3

232996.4

71541.0

e6/l

0.57

213

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

441

1.62

3.67

1.5

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

592

1.53

3.64

1.9

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

442

1.62

3.64

1.5

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

388

1.66

3.64

1.1

—

(3003338) MCHC [Mass/volume]

3508

33868

1.13

3.59

24.1

16.1

333.0

g/l

0.12

3488

33595

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

144

2.09

3.52

2.7

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

597

1.52

3.52

1.1

1.2

—

(3045716) Anion gap in Serum or Plasma

158

2.03

3.49

1.8

2.1

8.6

9.3

mmol/l

0.48

125

(3038026) Centromere Ab [Units/volume] in Serum

250

1.81

3.48

1.3

1.2

—

69.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

599

1.51

3.47

1.7

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.54

3.46

1.1

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

169

1264

1.35

3.43

2.2

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.35

3.40

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

101

2.28

3.35

1.2

—

(3020491) Glucose [Moles/volume] in Blood

246

1.80

3.35

2.1

2.0

7.0

6.5

mmol/l

0.71

178

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.25

3.34

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

133

963

1.39

3.32

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.62

3.30

1.2

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

112

796

1.42

3.13

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

336

1.64

3.09

1.7

1.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

102

716

1.43

3.06

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

102

716

1.43

3.06

1.4

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.24

3.05

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.68

3.05

1.1

1.4

29.5

5.5

u/ml

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

123

893

1.39

3.05

1.4

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.29

2.99

2.1

1.9

34.9

46.9

umol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

100

2.21

2.99

2.0

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.64

2.96

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

183

1.86

2.95

1.8

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

180

1393

1.30

2.94

2.3

1.9

—

(44790047)

404

1.57

2.92

1.7

1.5

—

(44790049)

404

1.57

2.92

1.7

1.5

—

(44806118)

404

1.57

2.92

1.7

1.5

—

(44790048)

404

1.57

2.92

1.7

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

468

1.52

2.92

1.7

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

183

1421

1.30

2.92

2.0

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

108

2.14

2.90

1.1

1.3

94.2

84.0

0.86

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.67

2.86

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

122

2.05

2.86

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

137

1025

1.35

2.84

1.2

1.3

73.3

194.2

titre

1.10

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

109

2.12

2.84

1.1

95.5

89.1

0.41

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

321

1.63

2.83

3.3

3.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

110

2.10

2.78

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.92

2.77

4.3

5.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.23

2.77

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

450

1.52

2.76

5.0

6.7

10.2

11.6

mg/l

2.06

416

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

500

1.49

2.73

1.1

3.2

u/ml

0.01

246

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

460

1.51

2.72

1.9

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

452

1.51

2.71

1.6

1.4

—

(3036603) Volume of Urine

241

1.71

2.69

1.5

1.8

1750.3

2012.7

0.67

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

206

1.75

2.61

1.5

1.6

—

(3017704) Immunofixation for Urine

177

1.81

2.59

1.4

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

275

1.64

2.58

1.1

278.5

285.9

mg/l

0.29

247

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

4.00

2.56

1.5

2.1

1.4

2.3

nmol/l

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

4.38

2.47

1.0

1.1

67.7

12.0

u/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

956

0.69

2.43

1.3

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

234

1.67

2.41

2.0

3.0

0.3

0.2

e9/l

1.01

203

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.95

2.41

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

416

1.50

2.41

3.5

2.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

242

1.66

2.40

2.0

2.9

833.0

466.1

e6/l

0.93

203

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

5.00

2.40

1.2

3.4

37.8

30.7

umol/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

124

1.94

2.40

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

539

0.59

2.35

2.6

3.7

27.6

29.8

u/ml

0.10

521

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

263

0.42

2.33

1.3

1.5

—

(44806420)

2.09

2.32

2.2

2.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

569

1.41

2.31

1.2

22.7

45.5

u/l

1.85

489

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

694

6244

1.13

2.31

1.8

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.05

2.31

1.0

1.1

2.2

39.8

u/ml

0.54

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.05

2.31

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

261

1.61

2.29

1.2

1.5

12.2

12.9

umol/l

0.27

243

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.38

2.29

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.38

2.29

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.38

2.29

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.62

2.27

1.2

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

122

932

1.32

2.26

1.5

2.2

0.0

g/l

0.50

101

855

(3020874) Milk IgE Ab [Units/volume] in Serum

239

1.64

2.25

1.1

21.9

3.6

u/ml

0.44

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

489

1.44

2.24

1.1

1.6

1.5

g/l

0.55

441

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

201

1.70

2.24

1.5

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

100

2.00

2.20

1.7

2.4

223.6

175.0

e6/l

0.54

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.78

2.20

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

241

1.62

2.18

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

120

920

1.31

2.18

1.6

2.2

0.0

g/l

0.00

101

853

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.34

2.18

1.1

2.1

1.6

umol/24h

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

149

1177

1.27

2.17

1.6

2.3

7.6

iu/ml

0.47

253

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

132

1027

1.29

2.16

1.8

2.7

182.0

192.2

0.58

122

981

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

289

1.56

2.16

1.2

1.4

65.9

67.4

pmol/l

0.02

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

337

1.52

2.16

3.8

3.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

151

1.79

2.15

2.1

2.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

378

1.49

2.15

1.2

1.1

63.0

67.8

u/l

0.15

253

(3006442) Creatine [Moles/volume] in Serum or Plasma

227

1.63

2.14

1.5

1.4

68.8

71.4

umol/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

387

1.48

2.13

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.37

2.12

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.05

2.11

1.3

1.2

—

(3000012) Reticulocyte production index

175

1.72

2.09

1.2

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

101

761

1.33

2.09

1.3

1.1

1.3

1.7

u/ml

0.24

292

(3014271) Vancomycin [Susceptibility]

138

1.82

2.08

3.7

2.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

472

4171

1.15

2.08

4.9

4.1

31.2

32.4

1.63

359

2749

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

105

796

1.33

2.08

1.6

2.0

2.5

4.7

iu/l

5.13

294

(3043238) Trisomy 21 risk [Likelihood] in Fetus

890

0.70

2.07

1.5

—

(3005033) Fetal Nuchal fold Thickness US

865

0.70

2.05

1.5

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

908

8354

1.11

2.04

2.9

0.8

ug/l

0.05

568

5522

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

162

2001

0.80

2.04

1.4

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.00

2.04

1.3

1.2

26.8

14.3

nmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

142

1125

1.27

2.03

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

437

3848

1.15

2.03

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.63

2.01

1.4

1.3

—

(3026480) Teichoate Ab [Titer] in Serum

2.82

2.00

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

155

1.75

1.99

2.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

155

1.75

1.99

1.6

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

155

1.75

1.99

1.6

1.7

—

(4306422)

510

1.40

1.99

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

613

1.36

1.97

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

869

0.71

1.96

1.5

1.4

—

(4038314)

3.34

1.96

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

142

1131

1.26

1.96

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1142

0.75

1.94

1.4

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.75

1.93

1.2

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

349

3037

1.16

1.92

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

760

0.69

1.92

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

516

1.38

1.87

1.2

1.3

5.1

3.9

u/ml

0.33

234

(3003888) Timothy IgE Ab [Units/volume] in Serum

688

1.33

1.87

1.1

4.7

6.1

u/ml

0.37

353

(3003740) Influenza virus B Ag [Presence] in Specimen

611

1.35

1.86

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1053

0.75

1.84

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.17

1.82

2.0

1.2

—

(3051651) Icteric interference index of Serum or Plasma

214

1.59

1.82

1.9

3.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.12

1.81

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.12

1.81

1.4

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.00

1.79

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

295

1.50

1.79

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

295

1.50

1.79

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

295

1.50

1.79

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.76

1.79

1.0

1.1

—

(3016750) Collection duration of Urine

216

1.58

1.76

2.5

2.2

525.6

485.5

min

1.56

166

(4015189)

2.09

1.75

1.5

2.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.50

1.74

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

490

1.37

1.73

1.1

122.3

114.8

1.04

448

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.67

1.72

1.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.92

1.72

1.1

—

(3044941) Cell count panel - Synovial fluid

551

1.35

1.71

1.6

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

647

1.32

1.70

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

450

4026

1.13

1.69

1.9

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

172

1.63

1.66

2.1

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.80

1.65

1.9

2.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1054

0.76

1.63

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1053

0.77

1.62

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

205

1.56

1.62

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

3.57

1.61

14.4

5.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

644

1.31

1.61

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

151

1.66

1.59

1.6

1.5

4.3

4.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1050

0.77

1.59

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

691

1.29

1.56

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

380

1.40

1.56

1.8

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.93

1.54

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.43

1.53

2.1

2.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.34

1.52

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

138

1134

1.22

1.51

1.7

2.5

95.5

89.7

2.60

122

1058

(4024509)

299

1.44

1.50

1.5

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

358

1.40

1.50

1.2

1.4

6.0

6.4

mmol/l

0.48

333

(3028308) Erythrocytes [#/volume] in Pleural fluid

409

1.37

1.49

1.4

88631.4

54506.1

e6/l

0.23

239

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

102

1.77

1.44

1.1

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

136

1123

1.22

1.43

1.9

2.8

3.8

3.6

g/l

0.63

127

1062

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

269

1.45

1.43

2.5

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.31

1.43

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

474

1.33

1.41

1.7

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.85

1.40

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.18

1.39

1.1

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

238

1.47

1.39

1.0

1.1

5.5

2.7

u/ml

0.24

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

119

1.68

1.37

1.4

1.2

0.3

g/l

0.51

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.20

1.37

1.7

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

521

1.31

1.35

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

248

1.46

1.35

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.13

1.33

1.3

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

664

1.27

1.33

1.1

1.5

1.2

u/ml

0.14

277

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

105

1.72

1.33

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.04

1.32

1.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.04

1.32

1.0

7.8

9.7

mg/g

0.38

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

113

1.68

1.31

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

160

1.57

1.31

1.3

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

863

0.77

1.30

1.6

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

604

1.28

1.30

1.5

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.36

1.29

1.5

3.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

153

1.57

1.28

1.0

1.1

97.3

91.5

0.41

125

(3028433) Virus identified in Specimen by Culture

122

1.64

1.27

1.4

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

448

1.32

1.27

1.4

1.5

2363.9

2170.0

e6/l

0.11

316

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.29

1.26

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.82

1.25

1.3

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.22

1.24

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

529

1.29

1.23

1.2

9.3

4.4

u/ml

0.57

169

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.00

1.23

1.0

—

(40768446) Kidney Pathology biopsy report

155

1.55

1.22

1.6

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.63

1.21

1.4

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.63

1.21

1.2

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

331

1.36

1.20

2.1

2.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

148

1.56

1.19

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

197

1.47

1.19

1.1

1.2

1.1

1.0

ratio

—

(44806071)

2.05

1.15

1.0

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

500

1.28

1.14

1.4

1.5

30.7

33.6

g/l

1.16

456

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

308

0.65

1.14

6.5

3.9

27.8

43.2

u/ml

1.08

308

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

275

1.38

1.13

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.34

1.12

1.1

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.00

1.12

2.1

2.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.90

1.12

27.1

10.9

5.3

6.1

mmol/l

0.56

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.90

1.12

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

111

1.62

1.12

1.0

—

(3014891) Appearance of Pleural fluid

1.96

1.11

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

108

1291

0.83

1.11

1.4

—

(3004775) Volume in Urine collected for unspecified duration

311

1.35

1.09

2.7

2.3

647.1

627.3

0.15

208

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.95

1.08

1.4

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.95

1.08

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

463

1.28

1.04

1.8

2.0

20.3

25.1

ug/l

0.36

457

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

487

0.74

1.04

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.63

1.03

1.3

1.6

—

(3000285) Sodium [Moles/volume] in Blood

1.92

1.02

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.69

1.01

1.4

2.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

328

2984

1.11

1.00

2.9

2.6

62.6

67.5

ml/min/173m2

1.42

161

1146

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

273

1.36

1.00

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.88

1.00

1.4

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.00

1.00

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

186

1637

1.14

1.00

2.7

3.5

60.8

57.1

u/ml

0.05

181

1584

(3051611) Lipemic interference index of Serum or Plasma

352

1.31

0.99

2.2

3.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

274

1.35

0.98

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

274

1.35

0.98

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

181

1.44

0.98

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

224

1.39

0.96

1.4

1.6

8.5

6.6

u/l

0.16

118

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

174

1.44

0.95

1.7

1.6

—

(3021788) Differential panel - Synovial fluid

614

1.23

0.94

1.7

1.6

—

(3042733) HLA Ab [Presence] in Serum

133

1.51

0.94

5.3

4.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

221

0.63

0.93

6.5

6.2

33.8

786.2

u/ml

—

(4034850)

137

1188

1.16

0.92

9.4

8.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

490

1.25

0.92

4.4

2.5

13.2

13.1

0.13

485

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

110

1.55

0.90

1.6

10.6

8.2

ug/l

1.50

110

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.07

0.89

1.0

1.1

—

13.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

219

1.37

0.89

3.9

7.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.79

0.87

1.1

1.3

127.4

92.3

ng/l

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

273

1.32

0.85

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

273

1.32

0.85

1.1

—

(3000330) Specific gravity of Urine by Test strip

206

1848

1.12

0.85

4.3

3.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

215

0.65

0.84

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

203

0.64

0.84

1.0

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

642

1.20

0.84

1.1

1.6

2.6

u/ml

0.54

159

(1617658) Protocol used for examination of sentinel lymph nodes

262

0.69

0.83

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.74

0.82

1.4

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

156

1.41

0.78

1.8

2.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.60

0.74

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

175

1.37

0.74

1.7

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

1.84

0.73

1.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

237

1.31

0.72

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.92

0.70

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.92

0.70

1.8

2.8

2.3

3.3

mg/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

203

1.33

0.70

1.6

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.85

0.68

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.64

0.68

3.0

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

864

0.85

0.66

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

494

1.20

0.66

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.57

0.65

1.5

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.61

0.65

1.3

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.72

0.64

1.0

6.4

18.4

u/l

—

(3033799) Differential panel - Peritoneal fluid

127

0.63

0.64

2.6

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

350

1.23

0.63

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

3648

36107

1.04

0.62

18.5

13.7

39.9

40.0

0.19

2515

26984

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.67

0.61

2.8

2.0

0.4

0.7

u/field

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

141

1270

1.11

0.60

1.5

1.3

246.9

226.2

miu/ml

0.23

607

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

518

1.18

0.60

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

105

1.43

0.60

1.2

—

(3045788) Cell count panel - Pleural fluid

354

1.22

0.58

1.7

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.51

0.58

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.72

0.57

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

355

1.21

0.57

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

266

1.24

0.55

1.9

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

133

1.35

0.55

2.1

2.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

133

1.35

0.55

2.1

2.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.48

0.53

1.1

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

797

1.13

0.53

2.8

3.7

147.8

881.2

u/ml

1.35

727

(3006922) Hepatitis E virus Ab [Presence] in Serum

259

1.24

0.52

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

341

1.20

0.52

1.2

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

135

1.33

0.51

2.1

2.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

144

1.32

0.50

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

539

1.15

0.49

1.1

1.6

3.8

u/ml

2.03

205

(21494434) Karyotype in Bone marrow

334

0.81

0.48

1.4

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

923

8950

1.04

0.48

2.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.47

0.47

4.6

5.9

—

(4268621)

374

1.18

0.46

2.5

2.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

228

1.23

0.45

4.1

2.3

—

(40768441) Liver Pathology biopsy report

285

0.81

0.43

1.3

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

461

1.15

0.43

2.3

2.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

248

1.21

0.42

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.64

0.42

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.40

0.42

1.4

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

131

1.30

0.42

4.1

2.7

19.8

88.9

au/ml

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

177

1.24

0.40

1.9

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

177

1.24

0.40

1.9

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

177

1.24

0.40

1.9

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

177

1.24

0.40

1.9

2.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

260

0.81

0.40

1.2

1.3

—

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

502

1.14

0.40

1.1

2.9

4.3

u/ml

0.34

197

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.40

0.0

1.3

—

4569.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.40

0.0

1.1

—

(3019174) dRVVT (LA screen)

1.43

0.39

1.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

381

1.16

0.39

2.0

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

438

1.14

0.38

1.1

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.35

0.37

7.2

7.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

107

1.31

0.37

23.1

7.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

225

1.20

0.37

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

152

1.25

0.37

1.1

—

(3034426) Prothrombin time (PT)

135

0.74

0.36

1.0

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

208

1.20

0.35

1.3

1.4

37.5

32.5

nmol/l

0.31

181

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

227

1.19

0.34

3.1

2.9

39.4

37.8

0.16

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

133

0.75

0.33

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

864

1.09

0.33

1.3

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

396

3817

1.04

0.31

3.3

4.4

30.7

22.9

ug/l

0.15

328

3134

(3012441) Differential panel - Pleural fluid

408

1.13

0.31

1.4

1.5

—

(40768793) Breast Pathology biopsy report

716

0.91

0.31

1.2

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

147

1.23

0.30

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

466

1.12

0.30

2.0

2.3

4.6

7.5

umol/l

1.25

345

(3035880) pH of Pleural fluid

212

1.18

0.30

1.1

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.25

0.29

1.0

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

111

0.72

0.28

3.0

3.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

173

0.81

0.28

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

158

1.20

0.28

1.1

1753.0

1559.4

miu/ml

0.31

158

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.27

0.27

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

168

1.19

0.27

4.9

3.4

—

(3002619) Bacteria identified in Specimen by Culture

0.69

0.26

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

415

0.89

0.26

1.2

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

203

0.84

0.25

1.2

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.22

0.25

5.8

7.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

133

1.20

0.24

2.1

1.3

—

(4281824)

360

1.11

0.23

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

307

0.88

0.23

1.4

1.6

0.9

g/l

0.94

307

(3025130) Human papilloma virus identified in Specimen

466

1.10

0.23

1.4

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.77

0.22

1.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

157

0.83

0.22

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

248

1.13

0.21

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.19

0.21

1.4

2.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

3.7

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

7.3

—

(3048879) Bone marrow aspiration report

103

0.78

0.21

1.3

2.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.16

0.21

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.16

0.21

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.20

0.0

1.6

—

(3024932) HLA-DR beta [Type]

136

1.18

0.20

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

334

0.90

0.20

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

250

1.12

0.19

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

279

1.11

0.19

1.3

1.2

—

(3011648) Oxygen content in Venous blood

290

1.10

0.18

3.2

2.6

11.2

11.1

0.07

290

(4211845)

185

1.14

0.18

4.7

3.3

—

(3024471) HLA-A [Type]

138

1.16

0.17

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.11

0.17

1.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

456

1.08

0.16

1.1

1.0

0.0

0.5

u/ml

—

(40768806) Pleura Pathology biopsy report

398

1.08

0.16

1.4

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

867

1.05

0.16

1.8

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.10

0.15

1.3

2.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

159

1.13

0.15

1.1

178.5

212.8

iu/ml

0.37

159

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

275

1.09

0.14

2.3

2.8

761.1

628.8

e6/l

—

108

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

181

0.88

0.14

1.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

181

0.88

0.14

1.2

1.6

—

(3003694) ABO and Rh group [Type] in Blood

1150

11394

1.01

0.13

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

106

0.85

0.13

3.1

3.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

142

1379

1.03

0.11

3.4

3.8

181.9

1948.3

u/ml

1.29

121

1180

(3047189) Immunofixation for 24 hour Urine

178

0.90

0.11

1.3

1.8

—

(4035726)

322

3275

0.98

0.10

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

280

1.07

0.10

1.1

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.15

0.10

27.1

7.1

—

(3035933) Granulocytes/100 leukocytes in Blood

125

1.12

0.10

9.0

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

4.6

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.09

0.09

1.0

1.3

5090.0

37.5

u/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

299

0.94

0.09

1.3

1.6

7.5

7.7

mmol/l

0.16

184

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

419

1.05

0.09

1.3

—

(3015183) Erythrocyte sedimentation rate

194

1.08

0.09

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

128

1312

0.97

0.08

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

134

0.90

0.08

1.2

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.83

0.08

1.2

1.3

—

147.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.78

0.08

1.6

4.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

198

2015

0.98

0.08

1.7

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.04

0.08

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.03

0.07

9.0

7.0

—

(40768800) Prostate Pathology biopsy report

965

1.03

0.07

1.3

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.84

0.07

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.84

0.07

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.84

0.07

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.84

0.07

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.07

0.07

1.4

1.3

—

(3044007) Cell count panel - Peritoneal fluid

110

1.09

0.05

2.8

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

130

1.08

0.04

1.6

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

101

1.09

0.04

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

121

1.07

0.03

1.0

—

(40765096) Chromosome analysis panel by Banding

123

1.06

0.01

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

376

0.98

0.00

2.1

3.9

51.1

57.4

0.87

223

(40768795) Lymph node Pathology biopsy report

365

0.99

0.00

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

104

0.96

0.00

1.3

41.7

455.1

ug/l

—

(3020650) Glucose [Presence] in Urine

1.03

0.00

1.2

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

117

1.03

0.00

1.6

1.7

—

(4133840)

111

0.99

0.00

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

509

1.00

0.00

1.3

3.2

4.2

ug/l

0.83

458

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.1

—

77.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

135.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

41.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

4.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.97

0.00

1.1

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.1

—

2423.8

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_SLEEPDISOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_SLEEPDISOTH	1.334 [1.19, 1.49]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.532

During the follow-up period (1.1.1998 — 31.12.2019), 1071 out of 9820 females with G6_SLEEPDISOTH died.

Males

Parameter	HR [95% CI]	p-value
G6_SLEEPDISOTH	1.354 [1.24, 1.48]	< 0.001
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2424 out of 14274 males with G6_SLEEPDISOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_SLEEPDISOTH.

N-year risk	Females	Males
1	0.118%	0.226%
5	0.882%	1.469%
10	2.276%	3.58%
15	4.204%	6.951%
20	7.155%	11.548%

Relationships between endpoints

↥

Index endpoint: G6_SLEEPDISOTH – Other sleep disorders

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other sleep disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints